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Assessment of Helicobacter pylori Infection as a Risk 
Factor for Coronary Artery Disease in Gaza Strip  
Abstract 
Background: Coronary artery disease (CAD) is a common form of 
cardiovascular disease (CVD). It caused by atherosclerosis, which restricts 
blood flow to the heart, and when the blood flow completely cut off, the result 
is heart attack. Cardiovascular disease remains the leading cause of death in 
the world as well as in Palestine. Helicobacter pylori (H. pylori) infection 
believed to be associated with CAD. 
Objective: Assessment of H. pylori infection as a risk factor for CAD in 
Gaza strip. 
Material and methods: This case-control study comprised 62 CAD 
patients (Cases: 31 males and 31 females) and 62 healthy controls (31 males 
and 31 females). Questionnaire interview was applied. Blood samples were 
collected, processed and analyzed. Serum H. pylori IgG, cholesterol, 
triglycerides, low density lipoprotein cholesterol (LDL-C), high density 
lipoprotein cholesterol (HDL-C), aspartate aminotransferase (AST), lactate 
dehydrogenase (LDH), creatinine phosphokinase (CK) and creatinine 
phosphokinase MB (CKMB) were determined. White blood cell (WBC), red 
blood cell (RBC), hemoglobin (Hb) and platelet (PLT) were also determined. 
Data were analyzed using SPSS version 18.0. 
Results: Coronary artery disease was more prevalent among less educated 
and unemployed individuals, families with low income, individuals with family 
history of the disease as well as among smokers. The number of cases who 
had diabetes mellitus, hypertension and peptic ulcer was significantly higher 
than that of controls. The BMI was significantly higher in cases compared to 
controls (31.7±4.8 vs 27.6±4.4, % difference=13.8 and P=0.000). There were 
significant elevations in the activities of serum AST and LDH in cases 
compared to controls (36.3±24.5 and 540.8±310.7 U/L vs 18.6±6.0 and 
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321.3±66.1 U/L, % difference=64.5 and 50.9, respectively P=0.000). Similarly 
CK and CKMB activities were higher in cases (225.7±216.1 and 22.7±15.5 U/L 
vs 101.2±50.0 and 11.4±4.9 U/L, % difference=76.2 and 67.8, respectively 
P=0.000). The levels of cholesterol, triglycerides and LDL-C were found to be 
higher in cases (208.9±47.6, 218.0±110.1 and 131.6±41.9 mg/dl, respectively) 
compared to controls (174.8±34.1, 167.4±57.7 and 104.4±31.2 mg/dl, % 
differences of 17.8%, 26.3%, and 23.1 and P=0.000, P=0.001, P=0.000 
respectively). On the other hand, the level of HDL-C was significantly lower in 
cases (33.7±9.8 vs 37.6±8.4 mg/dl, % difference=10.9, P=0.020). The WBC 
count was significantly higher in cases compared to controls (9.80±3.3 vs 
7.8±1.6 ×109/L, % difference 22.7, P=0.000), whereas RBC count, 
hemoglobin content and PLT count did not show significant differences 
between cases and controls (P>0.05). The prevalence of H. pylori among 
CAD patients 46 (74.2%) was significantly higher than controls 26 (41.9%) 
with P=0.000. When related to H. pylori, serum triglycerides was significantly 
increased in H. pylori positive cases more than in negative cases 
(235.8±112.8 vs 166.6±85.7mg/dl, P=0.029), whereas HDL-C level was 
significantly lower in positive cases (31.7±8.0 vs 39.5±12.3 mg/dl, P=0.005). 
The WBC count was significantly higher in positive compared to negative 
cases (5.01± 3.1 vs 7.9±205 P=0.007). 
Conclusions: H. pylori infection was significantly higher in CAD patients 
compared to controls. H. pylori infection was associated with higher 
triglyceride levels and WBC count, and lower HDL-C levels, and. Therefore, 
monitoring of H. pylori infection as a possible risk factor of coronary artery 
disease is of clinical value. 


















انز٘ ًُٚغ  ٍْٕٔ ٚحذد َخٛضت نخصهب انششاٚٛ، ْٕ أكزش اشكبل ايشاض انقهبيشض انششٚبٌ انخبصٙ : مقذمت
انؼبنى  نهٕفبة فٙ االٔل انًؤد٘ ايشاض انقهب ؼذحٔ، ٔػُذيب ٚخٕقف انذو حًبيب حقف ػعهت انقهب، حذفق انذو نهقهب
 .ًشض انششٚبٌ انخبصٙب، كًب ٚؼخقذ بأٌ اإلصببت ببنضشرٕيت انًهٕٚت انبٕابٛت يشحبطت قطبع غضةٔ
فٙ ًشض انششٚبٌ انخبصٙ نحٓذف انذساست إنٗ حقٛٛى اإلصببت ببنضشرٕيت انًهٕٚت انبٕابٛت كؼبيم اخخطبس الهذف: 
 قطبع غضة.
 15)انششٚبٌ انخبصٙ حبنت يشظٛت يٍ يشظٗ  22اشخًهج ْزِ انذساست انًشٓذة ػهٗ  الطرق واألدواث:
، ٔقذ حى ػًم يقببالث حى إَبد( 15ركٕس،  15) شخصب يٍ األصحبء كؼُٛبث ظببطت 22ٔإَبد(  15ركٕس، 
ٕبٕٛنٍٛ حى قٛبط كم يٍ انضه حٛذفٛٓب حؼبئت االسخبٛبَبث، كزنك صًؼج ػُٛبث انذو رى حى يؼبنضخبْب ٔححهٛهٓب، 
انبشٔحٍٛ انشحًٙ خفٛط  لكٕنسخشٔ، انذٌْٕ انزالرٛت، لانكٕنسخشٔ، ػٙ س نهضشرٕيت انًهٕٚت انبٕابٛتانًُب
كزنك حى قٛبط كم يٍ خالٚب انذو انبٛعبء،  .اَضًٚبث انقهب، انبشٔحٍٛ انشحًٙ يشحفغ انكزبفت لكٕنسخشٔانكزبفت، 
 .صهٕبٍٛانًٕٓٛيحخٕٖ  خالٚب انذو انحًشاء، ٔانصفبئح انذيٕٚت
 نخحهٛم انبٛبَبث ٔانُخبئش. SPSS-18.0اسخخذو انبشَبيش اإلحصبئٙ  
األشخبص األقم حؼهًٛب ٔاألشخبص غٛش  ٚؼذ أكزش اَخشبسا بٍٛانششٚبٌ انخبصٙ  يشضبُٛج انُخبئش بأٌ النتائج: 
كًب بُٛج . انًذخٍُٛباإلضافة إلى  األشخبص رٔ٘ انخبسٚخ انؼبئهٙ نهًشضٔانؼبئالث األقم دخال انًٕظفٍٛ ٔ
ػُذ انحبالث انًشظٛت  انٓعًٛت ٔانقشحتانًشحفغ  ٔظغػ انذو انسكش يشضانُخبئش ٔصٕد اسحفبع فٙ اَخشبس 
ػُذ  فٙ يؤشش كخهت انضسى ْٔزِ انُخٛضت راث دالنت إحصبئٛت. كًب بُٛج انُخبئش ٔصٕد اسحفبعيقبسَت ببألصحبء، 
كًب بُٛج انُخبئش ٔصٕد صٚبدة راث دالنت . دالنت إحصبئٛتانحبالث انًشظٛت يقبسَت ببألصحبء، ْٔزِ انُخٛضت راث 
. بشكم يشببّ ٙ انحبالث انًشظٛت يقبسَت ببألصحبءف (LDH)ٔاَضٚى (AST)   َضٚىاٍ إحصبئٛت فٙ َشبغ كم ي
فٙ انحبالث انًشظٛت يقبسَت (CKMB) ٔ اَضٚى  (CK) ٚىاَض ٔصٕد صٚبدة راث دالنت إحصبئٛت فٙ َشبغ كم يٍ
انبشٔحٍٛ انشحًٙ  لكٕنسخشٔ والدهون الثالثية و لالكولستروأشارت النتائج إلى أن كل من  كماببألصحبء، 
وهذه الزيادة ذات داللة إحصائية0 من ناحة  قد ازدادت في الحاالت المرضية مقارنة باألصحاء، خفٛط انكزبفت
، كًب ٔصذ داللة إحصائية وهذه الزيادة ذات انبشٔحٍٛ انشحًٙ يشحفغ انكزبفت لكٕنسخشٔأخرى وجد انخفاض في 
اسحفبع رٔ دالنت إحصبئٛت فٙ أػذاد كشاث انذو انبٛعبء ػُذ انحبالث انًشظٛت يقبسَت ببألصحبء، بًُٛب نى حظٓش 
 الصفائح الدمويةأػذاد و انُخبئش فشٔقبث راث دالنت إحصبئٛت فٙ أػذاد كشاث انذو انحًشاء ٔيحخٕٖ انًٕٓٛصهٕبٍٛ
 ء.بٍٛ انحبالث انًشظٛت ٔاألصحب
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، كًب انششٚبٌ انخبصٙ يقبسَت ببألصحبءٔأظٓشث انُخبئش صٚبدة فٙ اَخشبس انضشرٕيت انًهٕٚت انبٕابٛت بٍٛ يشظٗ 
أظٓشث انُخبئش ٔصٕد صٚبدة فٙ يسخٕٚبث انذٌْٕ انزالرٛت ػُذ انحبالث انًشظٛت انًصحٕبت ببنضشرٕيت انًهٕٚت 
ٕيت انًهٕٚت انبٕابٛت، ْٔزِ انُخٛضت راث دالنت إحصبئٛت، انبٕابٛت أكزش يٍ انحبالث انًشظٛت انغٛش يصحٕبت ببنضشر
انبشٔحٍٛ انشحًٙ يشحفغ انكزبفت ػُذ انحبالث  لكٕنسخشٔبًُٛب ٔصذ اَخفبض رٔ دالنت إحصبئٛت فٙ يسخٕٖ 
. كزنك ٔصذ اسحفبع رٔ دالنت إحصبئٛت فٙ ػذد كشاث انذو انبٛعبء ػُذ انحبالث شظٛت انًصحٕبت ببنضشرٕيتانً
 ًصحٕبت ببنضشرٕيت انًهٕٚت انبٕابٛت.انًشظٛت ان
 انششٚبٌ انخبصٙأشبسث انُخبئش بأٌ اإلصببت ببنضشرٕيت انًهٕٚت انبٕابٛت أػهٗ ػُذ يشظٗ االستنتاجاث: 
ببنًقبسَت يغ األصحبء، ْٔزِ انُخٛضت راث دالنت إحصبئٛت، ٔأظٓشث انُخبئش بأٌ اإلصببت ببنضشرٕيت انًهٕٚت 
انبشٔحٍٛ انشحًٙ يشحفغ انكزبفت ٔػذد كشاث انذو انبٛعبء،  لكٕنسخشٌٕٔ انزالرٛت، انبٕابٛت يقخشَت بكم يٍ انذْ
 نّ قًٛت سشٚشّٚ.انششٚبٌ انخبصٙ نًشض نزنك فئٌ انخحكى ببإلصببت ببنضشرٕيت انًهٕٚت انبٕابٛت كؼبيم اخخطبس 
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1.1 Overview  
 
Cardiovascular diseases (CVD) or heart diseases are the class of diseases that 
involve the heart or blood vessels. The various diseases that fall under the 
umbrella of heart disease include coronary artery disease (CAD), heart rhythm 
problems (arrhythmias), heart infections and heart defects including congenital 
heart defects (Gaziano, 2005; Centers for Disease Control and Prevention 
CDC, 2009 and American Heart Association, AHA, 2013). Heart failure is a 
common clinical syndrome that represents the final stage of a range of different 
heart diseases (Haldeman et al., 1999 and Anderson et al., 2007). 
 
Coronary artery disease is a common form of CVD and it is the major source of 
morbidity and mortality in the developing and developed countries (Walter, 2008). 
It is caused by atherosclerosis which restricts blood flow to the heart and when the 
blood flow is completely cut off, the result is heart attack (CDC, 2009 and 
Sakakura, 2013). The major risk factors involved in the development of 
atherosclerosis include hyperlipidemia, hypertension, smoking, and diabetes 
mellitus (Marković et al. 2011). The pathogenesis of atherosclerosis involves the 
processes of vascular injury, inflammation, degeneration, and thrombosis (Singh, 
2002 and Weber and Noels, 2011). 
 
Helicobacter pylori (H. pylori), is a gram negative spiral shaped bacterium that is 
found in the gastric mucous layer or adherent to the epithelial lining of the 
stomach. The presence of H. pylori confers a six fold increased risk of gastric 
adenocarcinoma, account for half of all gastric cancers and strongly implicated in 
the development of gastric B cell mucosa associated lymphoid tissue (MALT) 
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lymphomas as well as it causes peptic ulcer disease (Morgner et al., 2000; 
Lehours and Yilmaz, 2007; Mehmood et al., 2010 and Kate et al., 2013). 
 
The first paper regarding ischemic cerebrovascular disease and H. pylori was 
published in 1997 (Danesh et al., 1997).  It was further supported by other studies 
from developing and developed countries (Markus and Mendall, 1998; Annuziata 
et al., 2003; Zade et al, 2009 and Park et al., 2011). More recent study from Iran 
(Vafaeimanesh et al. 2013) documented the association between H. pylori 
infection and CAD. The study involved 62 CAD patients and 58 controls. 
Helicobacter pylori was more prevalent among patients with CAD and with 
increasing the number of coronary arteries with stenosis, the H. pylori seropositivity 
increased so that 76.3% of patients with multiple vessel diseases (MVD) and 70% 
of patients with single vessel diseases (SVD) were H. pylori seropositive versus 
50% in control group and this difference was statistically significant between 
groups (P=0.006). In Gaza strip, only two recent studies investigated H. pylori 
infection in malnutrition and type 2 diabetes medical services patients (Abu Jabal, 
2012 and Saadallah, 2013). The present study is the first to assess H. pylori 
Infection as a risk factor for CAD in Gaza strip. 
 
1.2 General objective  
To asses H. pylori infection as a risk factor for CAD in Gaza strip. 
 
1.3 Specific objectives  
1. To determine the prevalence of H. pylori infection among CAD cases 
compared with controls. 
2. To estimate cardiac enzymes including aspartate aminotransferase (AST), 
lactate dehydrogenase (LDH), Creatinine phosphokinase (CK) and 
Creatinine phosphokinase MB (CKMB) in cases and controls. 
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3. To measure lipid profile including cholesterol, triglycerides, high density 
lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-
C) in cases compared to controls. 
4. To evaluate blood parameters including white blood cell (WBC), red blood 
cell (RBC), hemoglobin (Hb) and platelet (PLT). 
5. To verify the relationship between H. pylori and the studied parameters in 
CAD patients. 
 
1.4 Significance  
1. Coronary artery disease becomes the first leading cause of death globally as 
well as among Palestinians according to Ministry of Health (Ministry of Health, 
MOH, 2010).  
2. To find out whether exposure to H. pylori infection is associated with CAD, this 
may be of a prognostic value. 
3. This is the first study to assess H. pylori infection as a risk factor for CAD 
patients in Gaza strip. 
4. Understanding the role of H. pylori in CAD could be useful in the management 




















2.1 Heart and coronary arteries 
The heart is a muscular (myocardium) organ that pumps blood throughout the 
blood vessels to various parts of the body by repeated rhythmic contractions. The 
human heart is located anterior to the vertebral column and posterior to the 
sternum and it is enclosed in a double-walled sac called the pericardium (Starr et 
al., 2009). The heart has four chambers, two superior atria (receiving chambers) 
and two inferior ventricles (discharging chambers). Oxygenated blood returns from 
the lungs into the left atrium, which pumps it into the left ventricle, whose 
subsequent strong contraction forces it out through the aorta leading to the 
systemic circulation (Marieb, 2011). Coronary arteries arise from aorta (Figure 
2.1). The right coronary artery gives branches to the walls of the right atrium and 
ventricle. The left coronary artery gives branches to supply the roots of the aorta 
and pulmonary trunk and the walls of the left atrium and ventricle. The left coronary 
artery bifurcates into the left anterior descending artery and the left circumflex 
artery. 
 
Figure 2.1. Coronary arteries of the heart (Encyclopedia of Science, 2013)  
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2.2 Definition of coronary artery disease  
Coronary artery disease, also known as coronary heart disease (CHD), coronary 
atherosclerosis and ischemic heart disease (IHD), which is a branch of CVD and a 
common form of heart disease. Coronary artery disease is considered as an 
insidious and dangerous disease in the world, and the major source of morbidity 
and mortality in the developed world (Walter, 2008 and European Society of 
Cardiology guideline, 2013). It is caused by atherosclerosis, an accumulation of 
fatty materials in the inner linings of arteries. The resulting blockage restricts blood 
flow to the heart and when the blood flow is completely cut off, the result is heart 
attack (CDC, 2009). 
 
2.3 Epidemiology of coronary artery disease  
According to World Health Organization fact sheet in 2007, CVD are the number 
one cause of death globally, more people die annually from CVD than from any 
other cause. An estimated 17.5 million people died from CVD in 2005, representing 
30% of all global deaths. Of these deaths, an estimated 7.6 million were due to 
CAD and 5.7 million were due to stroke. Over 80% of CVD deaths take place in 
low- and middle-income countries and occur almost equally in men and women. By 
2015, almost 20 million people will die from CVD, mainly from heart disease and 
stroke (World Health Organization, WHO, 2007). 
Cardiovascular diseases affect many people in middle age, very often severely 
limiting the income and savings of affected individuals and their families. 
Cardiovascular diseases place a heavy burden on the economies of countries. 
Lower socioeconomic groups in high-income countries generally have a greater 
prevalence of risk factors, diseases and mortality. A similar pattern is emerging as 
the CVD epidemic evolves in low and middle-income countries (Gersh et al., 
2010). 
 In the United Kingdom, CVD accounted for almost 198,000 deaths in 2006. Each 
year CVD causes over 2 million deaths in the European Union (EU), representing 
42% of all deaths in the EU (British Heart Foundation, 2008). Furthermore in 
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Canada every 7 minutes someone dies from heart disease or stroke; CVD 
accounted for 31% of all deaths in Canada. Moreover, estimates for the year 2006 
are that 80 million people in the United States have one or more forms of 
cardiovascular diseases; CAD caused about half million deaths and is the single 
leading cause of death in America today (AHA, 2009). 
In the Eastern Mediterranean region (Bahrain, Cyprus, Egypt, Iran, Iraq, Jordan, 
Kuwait, Oman, Qatar, the United Arab Emirate) CVD are emerging as a major 
health problem. The proportion of death from CVD ranges from 25 to 45%. 
Coronary artery disease seems to be the predominant type of cardiomyopathy 
encountered in many of these countries, and hospital data indicate rising trends. 
Several of these countries have experienced rapid socioeconomic changes over 
the last two decades. Daily caloric intake has increased (Heart Encyclopedia, 
1990). Approximately 37% of adults reported having two or more risk factors of 
heart disease and stroke including high blood pressure, high serum cholesterol 
level, diabetes, smoking, and obesity (Hayes et al., 2005). 
In Palestine, CVD principally heart disease, is the first leading cause of death 
among Palestinians (MOH, 2010). A total of 1088 cases from 3406 in Gaza strip, 
with proportion of 31.9%, died from CVD while mortality among males was higher 
than females (591 males vs 497 females, 54.3% in males vs 45.7% in females), 
and 1708 from 5581 with proportion of 30.6% in the west bank died from CVD 
while mortality among males was higher than females (966 males vs 742 females, 
56.6% in males vs 43.4% in females) (MOH, 2010). 
 
2.4 Pathophysiology of coronary artery disease  
Coronary artery disease is caused by coronary artery atherosclerosis which refers 
to the presence of atherosclerotic changes within the walls of the coronary arteries. 
The process of arterial narrowing with atherosclerotic plaque development is called 
atherogenesis which appears to be initiated and/or facilitated by chronic injury to 
the endothelium (Hansson, 2005). Low density lipoprotein compound bounds to 
LDL receptor, internalized, and transported through the endothelium the oxidative 
 7 
modification of LDL (Figure 2.2). The Oxidized LDL (OxLDL) contributes to 
atherogenesis by the following (Stocker et al., 2004):- 
1. Aiding the recruitment of circulating monocytes into the intimal space 
2. Inhibiting the ability of resident macrophages to leave the intima 
3. Enhancing the rate of uptake of the lipoprotein with leads to foam cell 
formation 
4. Be a cytotoxic by leading to loss of endothelial integrity 
Therefore, many of substantial evidences have documented that the development 
of CAD involves lipid oxidation and formation of oxygen radicals and that 
atherosclerosis with inflammation are associated with formation of oxygen and 
peroxyl radicals (Tigran et al., 2005). 
 
The macrophages remove OxLDL via scavenger receptors by forming the foam 
cells which are lipid filled macrophages (Rocha and Libby, 2009 and Emedicine, 
2013). The accumulated plaques of core lipid, thick fibrous filled with inflammatory 
cells as macrophage and T cells may be ruptured in response to the physical 
forces of blood flowing inside swelling of artery wall (Stocker et al., 2004). Blood 
platelets begin to accumulate at the site of a vulnerable coronary plaque and to 
initiate thrombotic occlusion of the coronary vessel (Meinrad, 2004 and Rocha 
and Libby, 2009).  
 
Figure 2.2. Pathophysiology of coronary artery disease (Rocha and Libby, 2009) 
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2.5 Risk factors of coronary artery disease 
2.5.1 Socioeconomic status  
In developing countries CAD risk factors are associated with lower level of 
education and income (Gupta, 2003). Studies conducted in other developed 
countries have provided convincing evidence of an inverse relationship between 
socioeconomic status (SES) and CAD. However, when multiple countries are 
compared, the relationship is quite variable, depending on the level of health 
transition in each country (Reddy et al., 2007). In addition, weighted data on self-
reported CAD and SES showed that self-reported CAD prevalence was generally 
higher among those of lower SES (Cunningham, 2010). In a recent US study, 
socioeconomic status based on a combination of income and education was 
significantly associated with estimated 10-year global CAD risk in all racial/ethnic 
groups except foreign-born Mexican American men (Karlamangla et al., 2010).  
 
2.5.2 Family history 
The study conducted by Kelalainen et al. (1996) in Finland has revealed that the 
family history of CAD was positively associated with cumulative occurrence of CAD 
events (Odds ratio 2.53; P=0.009). In addition, a study carried out by Sesso et al. 
(2001) has revealed that family history of premature CAD is an independent risk 
factor for CAD events. 
Nasir et al. (2004) assessed the association of a family history of premature CAD 
with coronary artery calcification (CAC) in 8549 asymptomatic individuals (69% 
men; mean age, 52±9 years) and compared the effects of sibling or parental family 
history on the risk of subclinical atherosclerosis. They demonstrated a highly 
significant association between family history of premature CAD and the presence 
and extent of CAC. A sibling history was more strongly associated with sub clinical 
coronary atherosclerosis than a parental history of premature CAD. 
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In a multi-Ethnic study of atherosclerosis on 5347 asymptomatic individuals (47% 
men; mean age 62±10 years), Nasir et al. (2007) showed an association between 
family history of premature CAD and the presence of any CAC. In addition, 
Braekkan et al. (2008) reported that family history of myocardial infarction 
remained a significant risk factor for total venous thromboembolism.  
In the European prospective investigation of cancer (EPIC)-United Kingdom 
cohort, Sivapalaratnam et al. (2010) tested whether adding family history of 
premature CAD in first-degree relatives improves risk prediction compared with the 
Framingham risk score (FRS) alone. The study comprised 10 288 men and 12 553 
women aged 40-79 years participating in the EPIC-Norfolk cohort who were 
followed for a mean of 10.9±2.1 years. A family history of CAD was indeed 
associated with an increased risk of future CAD, independent of established risk 
factors (FRS- adjusted Hazard Ratio of 1.74 (95% CI 1.56 to 1.95) for family 
history of premature CAD).  
Hasanaj et al. (2013) assessed whether CHD risk assessment is improved when 
family history information is added to other clinical information recommended in 
guidelines. Data reveled that family history was an independent risk factor for CHD 
(odds ratio=1.7, 95% confidence interval=1.26–2.47) and improved discrimination 
beyond guideline-defined clinical factors (P<0.006). However, the difference in the 
area under the curve of 2.8% and the extent of patient reclassification resulting 
from the inclusion of family history were small (P=0.11). 
 
2.5.3 Smoking  
The impact of smoking on the risk of non-fatal acute myocardial infarction (MI) in 
young middle age people was studied (Mähönen et al., 2004). The prevalence of 
smoking in people aged 35–39 years who experienced non-fatal MI events was 
81% in men and 77% in women. It declined with increasing age to 45% in men 
aged 60–64 years and 36% in women, respectively. In the 35–39 years age group 
the relative risk of non-fatal MI for smokers was 4.9 (95% confidence interval (CI) 
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3.9 to 6.1) in men and 5.3 (95% CI 3.2 to 8.7) in women, and the population 
attributable fractions were 65% and 55%, respectively. The authors concluded that 
during the study period more than half of the non-fatal MIs occurring in young 
middle age people can be attributed to smoking.  
In developing countries about 2.41 million premature deaths from cardiovascular 
causes were attributed to smoking (Hossain et al., 2007). In addition, Mannan et 
al. (2011) concluded that age at quitting of smoking improves the prediction of risk 
of CAD incidence even after other smoking measures are taken into account. 
Sadeghi et al. (2013) analyzed data of 120 patients, 92 (73.6%) were male, 113 
(90.4%) were married, 58 (46.4%) were smokers, 19 (15.2%) were opium users, 
97 (77.6%) had dyslipidemia, 44 (35.2%) had hypertension, and 33 (26.4%) had 
diabetes mellitus. In addition, family history was presented in 54 patients (43.2%). 
Among the study population, 120 patients (96%) had at least one of the traditional 
risk factors, including dyslipidemia, hypertension, diabetes mellitus, cigarette 
smoking, and family history of CHD. However, none of the dyslipidemic patients 
had controlled total cholesterol, LDL-C, HDL-C, and triglyceride. Also, none of the 
diabetic patients had hemoglobin A1C<7%. Among the 44 hypertensive patients, 
blood pressure of 15 ones (34%) was within the normal range. 
 
2.5.4 Physical activity 
Wannamethee and Shaper, (1997) in United Kingdom conducted a prospective 
study of 5159 subjects and indicated that there was an inverse relationship 
between CAD rates and physical activity with lowest rates in men undertaking 
moderate physical activity. On the other hand, Wannamethee et al., (2000) 
reported that regular moderate physical activity, such as rapid walking or similar 
levels of exertion, is associated with a 30-50% reduction in the risk of CHD. In this 
regard United Kingdom Department of Health guidelines recommend at least 30 
min of moderate activity on most days of the week will reduce the risk of CHD by 
30-50% (Bassuk and Manson 2005). 
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Fransson et al. (2006) assessed whether little physical activity in leisure-time 
compensates for the increased risk of AMI associated with overweight and obesity. 
Results was associated with a decreased risk with subjects with BMI less than 30 
kg\high square which means among lean, normal-weight and overweight subjects, 
but not among (BMI >30) obese subjects. While obese persons had an almost 
twofold risk of myocardial infarction even if he physically active person, compared 
with normal-weight and sedentary persons (OR 1.85, 95% CI 1.07-3.18). The 
results were similar for both genders. 
Weinstein et al. (2008) revealed that higher BMI and physical inactivity were 
individual predictors of CHD. In addition, Lightfoot et al. (2010) reported that 
physical activity interventions increase lifespan and improved the quality of life of 
heart patients. Furthermore, Stewart et al. (2013) concluded that low physical 
activity was only partly explained by cardiovascular symptoms 
 
2.5.5 Obesity 
Research articles indicated that obesity independently predicts CAD. This relation 
appears to exist for both men and women with minimal increases in BMI. Relations 
between categories of BMI, CAD risk factors, and vascular disease end points 
were examined prospectively in Framingham Heart Study participants aged 35 to 
75 years, who were followed up to 44 years (Wilson et al., 2002). The age-
adjusted relative risk (RR) for new hypertension was highly associated with 
overweight status (men: RR, 1.46; women: RR, 1.75). New hyper cholesterol and 
diabetes mellitus were less highly associated with excess adiposity. The age-
adjusted RR (confidence interval [CI]) for CAD was increased among those who 
were overweight (men: 1.21 [1.05-1.40]; women: 1.20 [1.03-1.41]) and the obese 
(men: 1.46 [1.20-1.77]; women: 1.64 [1.37-1.98]). High population attributable risks 
were related to excess weight (BMI ≥25) for the outcomes hypertension (26% men; 
28% women), angina pectoris (26% men; 22% women), and CAD (23% men; 15% 
women). 
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Shiraishi et al. (2006) examined the relation of obesity to AMI in 1260 Japanese   
AMI patients. In young, middle-aged, and older males, as well as in older females, 
cases had higher BMI than controls. Except for very old males, the prevalence of 
hyper cholestermia, hypertension, and diabetes mellitus were higher in each 
subgroup of cases than in controls. Multivariate logistic regression analysis 
revealed that obesity (BMI≥25) was an independent risk for AMI in young and 
middle aged males, but not in female. The authors concluded that obesity is 
significantly associated with AMI, independent of the classic coronary risk factors, 
in young and middle-aged males. In addition, Yao et al. (2007) demonstrated that 
BMI as a measure of overall adiposity in Chinese sample of 2334 is strongly 
associated with increased prevalence of CAD independent of metabolic syndrome. 
In their review study entitled "Obesity and coronary artery disease: risk factor, 
paradox, and impact of weight loss", Lavie et al. (2009) reported that obesity had 
a major impact on CVD, such as heart failure, CAD, sudden cardiac death and 
atrial fibrillation, and is associated with reduced overall survival. Even in children, 
Jonge et al. (2011) pointed out that obese children had a greater left ventricular 
mass (1.04 SD score [95% CI: 0.20 to 1.89]) and a higher fractional shortening 
(0.91 SD score [95% CI: 0.02 to 1.80]). 
 
2.5.6 Diabetes mellitus 
A prospective study was carried out on 1059 type 2 diabetic patients aged 45-64 
years in Finland to investigate the risk of lipid and glucose abnormalities and the 
occurrence of CAD (Lehto, 1997). Results showed that low HDL-C, high LDL-C 
(≥5.2 mmol/l), high triglyceride level (>2.3 mmol/l), and high fasting plasma glucose 
(>13.4 mmol) was independently associated with twofold increase in the risk of 
CAD, while high fasting glucose (>13.4 mmol/l) with low HDL-C, low HDL-C/TC 
ratio, or high total triglyceride increase the risk of CAD events to threefold. In 
addition, Vilbergsson et al., (1998) has indicated that type 2 diabetes increased 
twice the risk of CAD mortality in male and female patients independently of other 
risk factors.  
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A prospective study of 514 patients with unstable angina or MI in Iran has 
investigated that the diabetes mellitus and hypertension are leading risk factors 
that may directly or indirectly interfere and predict more serious complications of 
CAD (Esteghamati et al., 2006). Another prospective study from Japan on 13355 
men and 15724 women who reported diabetes in a questionnaire has revealed that 
diabetes increases the risk of mortality from CAD among men and that from cancer 
among women (Oba et al., 2008). 
Borg et al., (2010) examined the association between various indices of glycaemia 
measured during everyday activities and metabolic CAD risk factors in the A1C-
Derived Average Glucose study. Participants (268 with type 1 diabetes, 159 with 
type 2 diabetes) completed 16 weeks of intensive continuous glucose monitoring 
and self-monitoring of blood glucose. For both diabetes types, the overall strongest 
associations with CAD risk factors were seen for the measures of average 
glycaemia (mean blood glucose and HbA1c). Associations between self-monitored 
postprandial and fasting glucose and CAD risk factors were weaker, but significant. 
Measurements of blood glucose variability showed non-significant associations. 
 Assareh et al. (2013) conducted a cross-sectional study on 333 patients who 
were admitted with diagnosis as a CAD and candidates for angioplasty in Iran. The 
prevalence of CAD risk factors in overall subjects were: 45.3% hypertension 
(considering >140/90 mmHg); 34.5% high cholesterol (>240 mg/dl); 27.6% diabetic 
mellitus (>126 mg/dL); family history of heart disease: 20.7%; smokers: 19.9%. 
  
2.5.7 Hypertension  
Many research articles about hypertension were carried out. Some discussing its 
impact on individual and community, others discussing the prevalence and its 
economic burden, in addition of studying its relationship with other CAD and other 
chronic disorders. A prospective cohort study in the Netherlands has indicated that 
there is a strong positive relationship between the occurrence of CAD and the 
elevated systolic and diastolic blood pressure (van den et al., 1996) 
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Demosthenes et al. (2005) evaluated the association of blood pressure 
measurements with CAD mortality among 12763 men, aged 40 to 59 years, from 7 
countries (United States, Japan, Italy, Greece, former Yugoslavia, Finland, and the 
Netherlands). All baseline blood pressure measurements were the best predictors 
of CAD mortality; compared with age, physical activity, total cholesterol, BMI, and 
smoking. Moreover, pulse pressure and diastolic and systolic blood pressures 
were the best predictors for CAD death, followed by mean and mid blood 
pressures. The age-adjusted hazard ratio (HR) per 10-mm Hg increase in pulse 
pressure varied among cohorts from 1.19 in the United States (P=0.04) to 1.29 in 
southern Europe (P=0.01). Differences among cohorts were not significant. In the 
pooled cohorts, pulse pressure measurements were also a significant predictor for 
CHD (HR per 10-mm Hg increase, 1.15; P=0.04) as well as stroke death (HR per 
10-mm Hg increase, 1.32; P=0.01). 
Dorjgochoo et al. (2009) determined whether various levels of blood pressure, 
particularly normal and high normal blood pressure or prehypertension can predict 
cardiovascular mortality among 68438 urban Chinese women. The authors 
identified 1574 deaths from all causes, 247 from stroke, and 91 from CHD. 
Hypertension and higher levels of individual blood pressure parameters including 
systolic blood pressure, diastolic blood pressure, pulse pressure, and mean arterial 
pressure, were positively associated with all-cause, stroke, and CHD mortality (P 
trend <0.05 for all except for diastolic blood pressure and CHD mortality). 
Prehypertension (adjusted hazard ratio (HR adj) =1.65; 95% CI, 0.98 2.78), 
particularly high normal blood pressure (HR adj =2.34; 95% CI, 1.32–4.12), was 
associated with an increased risk of mortality from stroke. Hypertension accounted 
for 9.3% of mortality from all causes, 25.5% of mortality from stroke, and 21.7% 
mortality from CHD. High normal blood pressure accounted for 10.8% of mortality 
from stroke. Isolated systolic blood pressure also predicted stroke and CHD 
mortality. 
Data on blood pressure collected from Canadian adults at 15 sites from March 
2007 through February 2009 showed that the prevalence of hypertension in adults 
was estimated at 19% (Kathryn et al., 2010). The authors emphasized that high 
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blood pressure is a major risk factor for heart and vascular disease and is an 
important cause of death around the world. In addition, CDC morbidity and 
mortality weekly report (2011) considered hypertension as a major modifiable 
risk factor for CVD that affects one in three adults in the USA and contributes to 
one out of every seven deaths and nearly half of all CVD–related deaths in the US. 
Oladapo et al. 2013 identified the relationship between CV risk factors and CVD. 
Commonest source of medical information was the family/friend/opinion leaders of 
trusted groups in 1198 (59.9%), the media (including radio, public enlightenment 
programmes, and newspapers) in 492 (24.6%), and the doctor/nurse/health worker 
in 183 (9.1%) of the respondents. About 56% of the respondents could not identify 
a single risk factor. They found that subjects who had more years of formal 
education, a positive family history of CVD, and self reported history of diabetes 
mellitus were more likely to have a good level of knowledge of hypertension and 
other CV risks when adjusted for age, gender and marital status. 
 
2.5.8 Lipid abnormalities 
A study enrolled 147 patients with CAD (97 men and 50 women, aged 25-82 
years) revealed that higher levels of remnant lipoproteins in fasting serum predict 
future coronary events in patients with CAD independently of other risk factors 
(Kugiyama et al., 1999). Patients with diabetes have low HDL-C, high LDL-C 
level, but they had significant elevated triglyceride level when compared with 
individuals with normal glucose tolerance, an increase of 10 mg/dl in LDL-C is 
associated with 12% increase in CVD risk. LDL-C blood level was considered as a 
strong independent predictor of CAD in diabetic patients (Howard, 2000).  
Washio et al. (2001) evaluated the effect of hypertension, dyslipidemia and 
diabetes mellitus on the development of coronary atherosclerosis in 433 Japanese 
patients (254 men and 179 women) aged 30 years or older who underwent 
coronary angiography for suspected or known CHD angina. The main outcome 
measure was angiographically defined coronary artery stenosis and was found to a 
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significant degree in 146 patients (33.7%). Hypertension, diabetes, low levels of 
HDL-C and hypertriglyceridemia remained as significant CAD risk factors even 
after controlling for age, sex, hospital, smoking, alcohol use, BMI and leisure time 
physical activity. However, hypercholesterolemia was not a significant risk factor 
after adjusting for these variables. After controlling for these variables, diabetes, 
low HDL-C and hypertriglyceridemia were significant CAD risk factors for men, but 
only DM was a significant CAD risk factor in women. 
Pischon et al. (2005) compared apolipoprotein B (apoB), non–HDL-C, LDL-C, and 
other lipid markers as predictors of CHD among 18225 men. A total of 266 had 
nonfatal myocardial infarction or fatal CHD during 6 years of follow-up. After 
adjustment for matching factors, the relative risk of CHD in the highest quintile 
compared with the lowest quintile was 2.76 (95% confidence interval [CI], 1.66 to 
4.58) for non–HDL-C, 3.01 (95% CI, 1.81 to 5.00) for apoB, 1.81 (95% CI, 1.12 to 
2.93) for LDL-C, 0.31 (95% CI, 0.18 to 0.52) for HDL-C, 2.41 (95% CI, 1.43 to 
4.07) for triglycerides (all P trend <0.001), and 1.42 (95% CI, 0.86 to 2.32, P trend 
=0.19) for lipoprotein(a). When non–HDL-C and LDL-C were mutually adjusted, 
only non–HDL-C was predictive of CHD. When non–HDL-C and apoB were 
mutually adjusted, only apoB was predictive; the relative risk was 4.18 (95% CI, 
1.30 to 13.49; P trend =0.02) for apoB compared with 0.70 (95% CI, 0.21 to 2.27; 
P trend =0.72) for non–HDL-C. Triglycerides added significant information to non–
HDL-C but not to apoB for CHD risk prediction. 
Associations between HDL-C and both stroke and CHD in the Asia Pacific region 
was investigated (Woodward et al., 2007). After adjustment for age and 
regression dilution, hazard ratios (95% confidence intervals) for a 1 standard 
deviation (SD)  lower level of HDL cholesterol (0.4 mmol/L) were: for CHD events, 
1.39 (1.22–1.57); for ischemic stroke, 0.90 (0.75–1.07), and for haemorrhagic 
stroke, 0.89 (0.74–1.07). As total cholesterol (TC) increased relative to HDL-c, the 
risk of CHD increased, the risk of ischemic stroke was unchanged but the risk of 
haemorrhagic stroke decreased. A 1 SD increase in TC/HDL cholesterol (1.63 
units) was associated with a 27% decrease in the risk of haemorrhagic stroke 
(95% confidence interval, 7– 44%). 
 17 
Di angilantonio et al. (2009) assessed major lipids and apolipoproteins in 
vascular risk among 302 430 people from Europe and North America. The rates of 
CHD per 1000 person-years in the bottom and top thirds of baseline lipid 
distributions, respectively, were 2.6 and 6.2 with triglyceride, 6.4 and 2.4 with HDL-
C, and 2.3 and 6.7 with non–HDL-C. Adjusted HRs for CHD were 0.99 (95% CI, 
0.94-1.05) with triglyceride, 0.78 (95% CI, 0.74-0.82) with HDL-C, and 1.50 (95% 
CI, 1.39-1.61) with non–HDL-C. Hazard ratio were at least as strong in participants 
who did not fast as in those who did. The HR for CHD was 0.35 (95% CI, 0.30-
0.42) with a combination of 80 mg/dL lower non–HDL-C and 15 mg/dL higher HDL-
C. For the subset with apolipoproteins or directly measured LDL-C, HRs were 1.50 
(95% CI, 1.38-1.62) with the ratio non–HDL-C/HDL-C, 1.49 (95% CI, 1.39- 1.60) 
with the ratio apo B/apo AI, 1.42 (95% CI, 1.06-1.91) with non–HDL-C, and 1.38 
(95% CI, 1.09-1.73) with directly measured LDL-C. Hazard ratios for ischemic 
stroke were 1.02 (95% CI, 0.94-1.11) with triglyceride, 0.93 (95% CI, 0.84-1.02) 
with HDL-C, and 1.12 (95% CI, 1.04-1.20) with non–HDL-C. 
In his study entitled " Impact of Hypertriglyceridemia on Endothelial Dysfunction 
During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease" 
Nakamura et al. (2011) concluded that hypertriglyceridemia is independently 
associated with endothelial dysfunction in patients with CHD during statin therapy. 
Ezetimibe add-on therapy improves endothelial function in these high-risk 
populations.  
Tripta and Sharma, (2013) evaluated the association of BMI, blood lipids and 
apolipoproteins level with CAD among 150 CAD patients aged 35-45 years; One 
hundred fifty normal controls were involved. The study demonstrated that CAD 
patients had elevated BMI in both males and females than normal controls.  Apo B 
levels were an important predictor of CAD.  ApoA/ApoB ratio among CAD patients 
was 0.74 compared with 1.53 in normal subjects; controls had 105.8% higher 
ApoA/ApoB ratio than CAD subjects. Total cholesterol, LDL-C, triglycerides, LDL-
C/HDL-C ratio of the two groups also showed significant differences. Prevalence of 
obesity in CAD patients was 70.7% compared with 10% in normal controls. 
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2.6 Helicobacter pylori 
2.6.1 Definition and general characteristic of H. pylori 
Helicobacter pylori is a spiral or slightly curved Gram negative rod with 2-6 
characteristic unipolar flagella (Figure 2.3). The bacterium has bluntly rounded 
ends and measures 2.5-4.0 μm in length and 0.5-1.0 μm in width. The cell wall is 
smooth and may be coated with a prominent glycocalyx with a thickness of up to 
40 nm (Goodwin et al., 1989). The flagella measure 2.5 μm in length and around 
30 nm in thickness, and have a distinctive terminal bulb (Goodwin & Worsley, 
1993). The bacterium displays remarkable motility in viscous solutions, and the 
flagella play a central role in this motility (Hazell et al., 1986 and Suerbaum et al., 
1993). Helicobacter pylori is a microaerophilic and under certain circumstances it 
can be U- shaped or coccoid (Enroth et al., 1999). It resides naturally in the 
gastrointestinal tract of humans and animals (Fox, 2002). In the stomach, the 
majority of H. pylori can be found in the gastric mucosa; however a few are found 
adhered to the gastric mucosal epithelium. The bacterium is highly adapted to 
survive in the hostile environment of the stomach where few other organisms can 
survive. Although H. pylori is considered to be an extra cellular bacteria, there is 
evidence suggesting that the bacteria has a mechanism for intracellular invasion 
(Kusters et al., 2006). 
 
Figure 2.3 Helicobacter pylori. The curved bacillus with unipolar flagella is visualized by a 
scanning electron microscope (Lembo, 2005). 
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2.6.2 Taxonomy of Helicobacter pylori 
The scientific classification of the H. pylori (Marshall & Warren, 1984) is: 
Kingdom: Bacteria 
Phylum: Proteobacteria 




Species: Helicobacter pylori 
2.6.3 Prevalence of Helicobacter pylori infection 
Infection with H. pylori has been recognized as a public health problem worldwide 
affecting approximately 50% of the world population (Bender et al., 2007 and 
Sachs and Scott, 2012). In developing countries the prevalence of H. pylori 
antibodies was found i n  more than 70% in the populations (Nurgalieva et al., 
2002 and Stasi et al., 2008). On the contrary, in developed countries, H. pylori 
infection is less common in young children and increases with age and reaches 
50% by adulthood (Lane et al., 2006 and Zhou et al., 2012). In the Gaza strip, 
Abu-Mughesieb study showed that the rate of H. pylori infection in Gaza strip is 
48.3% (Abu-Mughesieb, 2007). In a recent study focused on H. pylori infection 
and malnutrition, Abu Jabal (2012) reported 70.5% prevalence of H. pylori among 
type 2 diabetic medical services patients in Gaza strip. 
2.6.4 Transmission  
A) Person-to-person route 
Humans are the only known significant reservoir of H. pylori (Collazo, 2012). 
Person to- person contact is believed to be the primary route of transmission in 
developed countries, and is also important in developing countries. Close personal 
contact, particularly within the family including mother/parents to child, sibling to 
sibling and spouse to spouse, has been consistently demonstrated as a risk factor 
for transmission of infection (Escobar and Kawakami, 2004 and Khalifa et al., 
2010). 
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B) Oral-oral route 
Helicobacter pylori deoxyribonucleic acid has been detected in the saliva of H. 
pylori positive subjects by polymerase chain reaction (PCR) (Khalifa et al., 2010 
and Collazo, 2012). Helicobacter pylori organisms have also been successfully 
detected from the dental plaque of infected persons (Sousa et al., 2006 and 
Rasmussen et al., 2010). In general, isolation has not been uniformly successful, 
however, perhaps as a result of the transient presence of H. pylori in the oral cavity 
or poor detection capability resulting from the co-occurrence of many other 
bacteria in the oral cavity. 
C) Fecal-oral route 
Fecal- oral is the main route of H. pylori transmission, H. pylori has been detected 
in faeces by culture and its DNA by PCR (Delport et al., 2007; Mishra et al., 2008 
and Momtaz et al., 2012), although other investigators have failed to replicate this 
patients (van Zwet et al., 1994). These data, together with those from Silva et al. 
(2009), documented the possible role of fecal shedding of H. pylori into the 
environment. 
D) Iatrogenic transmission 
Endoscopes used routinely in upper gastrointestinal procedures may be the source 
of iatrogenic infection as a result of improper disinfection between procedures 
(Brown, 2000). 
2.6.5 Signs and symptoms of H. pylori infection  
Most people with H. pylori infection are asymptomatic, but a proportion of infected 
individuals develop severe gastro duodenal disease, including duodenal ulcer, 
gastric ulcer, gastric adenocarcinoma and gastric Mucosa Associated Lymphoid 
Tissue (MALT) lymphoma (Chen et al., 2013; Shiota et al., 2013 and 
Witkowska and Smolewski, 2013). Acute H. pylori infection in adults is 
accompanied by mild to moderate dyspeptic symptoms and occasional vomiting, 
which appear few days after challenge, peak during the second week and then 
resolve. The clinical course of chronic H. pylori infection is highly variable and 
influenced by microbial, host and environmental factors. In virtually all infected 
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individuals H. pylori causes chronic inflammation in the gastric mucosa gastritis 
develops rapidly after acquisition of H. pylori infection and persists through several 
years of the infection, chronic gastritis may gradually progress to atrophic gastritis 
(Oona et al., 2004 and Vale and Vítor, 2010). 
2.6.6 Diagnosis of H. pylori infection 
Diagnosis of H. pylori infection is usually made by checking for dyspeptic 
symptoms and by tests which can indicate H. pylori infection (Stenström et al., 
2008). The diagnostic tools for H. pylori are serology, Rapid Urease Test (RUT), 
Urea Breath Test (UBT), Endoscopy and Biopsy/Histopathology, PCR, for DNA of 
H. pylori and Helicobacter pylori Stool Antigen (HpSA) (Tiwari et al., 2005). The 
simplest test of H. pylori is serologic, including the assessment of specific IgG level 
in serum (Suerbaum et al., 2002). 
2.6.7 Pathogenic mechanisms of H. pylori which predispose to 
coronary artery disease 
In addition to its association with severe gastrointestinal pathologies (Nguyen et 
al., 2010 and Türkay et al., 2011), H. pylori is associated with other conditions 
such as CAD, diabetes mellitus and some autoimmune diseases (Manco et al., 
2010 and Assal et al., 2013). Several hypotheses were presented for confirmation 
of higher prevalence of H. pylori infection that may induce or accelerate 
atherosclerosis (Yamaoka et al., 2002). Chronic infection of H. pylori increase the 
production of various metabolites, such as inflammatory cytokines, that affect the 
blood flow in vessels and cause endothelial dysfunction and further shrinkage of 
small vessels (Tsai et al., 2001 and Annuziata et al., 2003). Elevated 
concentrations of cytokines in the gastric mucosa of H. pylori infected patients 
could increase serum fibrinogen and leukocytes. It seems that inflammatory 
response and related reactions in patients with H. pylori infection could justify 




2.7 Related studies 
Sebastián et al. (2001) investigated the presence of H. pylori in 38 atherosclerotic 
plaques obtained at carotid endarterectomy by using morphological and 
immunohistochemical (intercellular adhesion molecule-1) techniques and a highly 
sensitive PCR method. They also examined 7 carotid arteries obtained at autopsy 
from subjects without carotid atherosclerosis. Helicobacter pylori DNA was found in 
20 of 38 atherosclerotic plaques. Ten of the H. pylori DNA–positive plaques also 
showed morphological and immunohistochemical evidence of H. pylori infection. 
None of 7 normal carotid arteries was positive for H. pylori. Intercellular adhesion 
molecule-1 was expressed in 75% of H. pylori–positive plaques and in 22% of H. 
pylori–negative plaques. The presence of the microorganism was associated with 
male sex but was independent of age, vascular risk factor profile, and prior 
neurological symptoms.   
The relationship between H. pylori infection and acute ischemic stroke in 62 
patients with their first stroke and 143 controls was investigated (Sawayama et al., 
2005). All patients underwent cranial CT scanning and/or brain magnetic 
resonance imaging, duplex ultrasonography of the extracranial carotid arteries, and 
transthoracic echocardiography. Helicobacter pylori infection was diagnosed by 
detection of anti-H. pylori IgG antibodies, the 13C-urea breath test, and histology. 
Chronic H. pylori infection was associated with a higher risk of stroke due to small 
artery occlusion (odds ratio: 9.68; 95% CI: 3.56–33.08, P < 0.001) and a lower risk 
of cardioembolic stroke (odds ratio: 0.27; 95% CI: 0.03–1.53). Chronic H. pylori 
infection still showed an overall association with ischemic stroke (odds ratio for all 
subtypes combined: 2.57; 95% CI: 1.09–6.08) after adjusting for major 
cardiovascular risk factors. 
Miyazaki et al. (2006) examined whether H. pylori infection is a risk factor in 33 
patients with acute coronary syndromes (ACS). A control group was consisted of 
66 males who had normal resting electrocardiogram and had no history of IHD. 
Helicobacter pylori seropositivity was determined by an IgG-specific ELISA. The 
presence of antibodies specific to the antigen CagA of H. pylori was confirmed, 
using CagA ELISA. Seropositive rate of IgG antibodies in patients with ACS was 
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87.9%. A rate in controls was 66.7%. After adjustment for age, a statistically 
significant association was found in H. pylori seropositivity between ACS and 
controls (OR, 3.74; 95% CI, 1.15–12.13). This relation was also significant after 
adjusted for potential confounding factors (OR, 4.09; 95% CI, 1.10–15.17). Anti-
CagA positive H. pylori were significantly recognized in ACS (adjusted OR, 3.58; 
95% CI, and 1.08–11.82). However, this significant association was disappeared 
after adjusted for potential confounding factors (P= 0.054). 
The seroprevalence of H. pylori in patients with CAD was determined (Veev et al., 
2007). Patients with CAD (n=90) and control group (n=90) were enrolled into 
randomized, multi-centre study. Coronary artery disease risk factors analyzed 
included age, male gender, diabetes mellitus, systemic hypertension, cigarette 
smoking, hypercholesterolemia and socioeconomic status. The results showed a 
higher seroprevalence of H. pylori infection in patients with CAD compared to 
controls (78.8% vs. 58.3%, P<0.05). However, H. pylori seropositivity was not 
associated with coronary artery risk factors (smoking, body mass index, diabetes 
mellitus, hypertension, total cholesterol and socioeconomic status) either in the 
whole study population or in the patients and control subjects analyzed separately 
(P>0.05). 
Nozari et al. (2009) investigated whether H. pylori infection is related to 
prevalence of CHD. The study was carried out on 130 subjects who underwent 
coronary angiography. According to angiography findings, the patients were 
grouped into cases (n=70) with CAD, and normal control group (n=60). Then, using 
ELISA method, specific anti H. pylori IgGs were measured in all subjects. Among 
the 130 patients, anti-H. pylori IgG were detected in 80% of cases and 65% of 
control subjects (P=0.05). The investigation showed that CAD correlated 
significantly with hypertension, diabetes, and smoking (P<0.05) although there was 
no associations between these traditional risk factors, and H. pylori infection. 
 
The relationship between H. pylori and MI was determined (Azarkar et al. 2011). 
Seventy-three MI patients and 78 individuals with no history of this disease were 
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compared. Patients and controls were matched for age and sex. Levels of serum 
IgA and IgG antibodies against H. pylori were measured by Elisa method. The 
percentage of IgG positive cases against H. pylori was 57.5% in the case group 
and 32.1% in the control group (P=0.002, OR: 2.87 CI: 95%; 1.5-5.6). Meanwhile, 
there was no significant difference in IgA positive cases between the two groups 
(42.5% and 48.7% in the case and control groups, respectively) (P=0.44; OR: 0.78 
95% CI; 0.41-1.48). The study showed 74.2% of cases in the case group and 
45.2% in the control group were positive for both IgG and IgA (P=0.01; OR: 3.5 
95% CI; 1.3-9.5). No significant differences were found between two groups in 
terms of relation between H. pylori related antibodies level and heart disease 
classic risk factors (smoking, hypertension,…), sex, and age, but between 
dyslipidemia and H. pylori related antibodies was significant differences in case 
group (P=0.05). 
 
Tewari et al. (2012) conducted a case control study (retrospective) over a two-
year period. The study population was divided into two groups with 200 individuals 
in each group. The first group comprised cases of CAD and the second comprised 
healthy controls selected from the general population after matching for age and 
sex. ELISA was done for immunoglobulin (IgG) antibodies to H. pylori, Chlamydia 
pneumoniae (C. pneumonia), and Cytomegalovirus (CMV). Seropositivity for H. 
pylori was present in 119 patients of CAD (59.5%) but it was present in only 76 
controls (38%) (P= 0.001). There was a statistically significant association between 
seropositivity for H. pylori and CAD. There was no statistically significant 
association between C. pneumonia and CMV seropositivity with CAD. Multiple 
logistic regression analysis was done with CAD as the outcome (dependent 
variable). The predictor covariates (independent) variables were seropositivity to H. 
pylori, C. pneumoniae, and CMV, hypertension, obesity, diabetes, and 
dyslipidaemia. It was found that seropositivity to H. pylori, hypertension, obesity, 
and dyslipidaemia were significant risk factors for CAD. 
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Vafaeimanesh et al. (2013) evaluated the association between H. pylori infection 
and CAD. The study involved 62 CAD patients and 58 controls. Helicobacter pylori 
was more prevalent among patients with CAD and with increasing the number of 
coronary arteries with stenosis, the H. pylori seropositivity increased so that 76.3% 
of patients with multiple vessel diseases (MVD) and 70% of patients with single 
vessel diseases (SVD) were H. pylori seropositive versus 50% in control group and 
this difference was statistically significant between groups (OR=3.86, 95%CI=1.48-
10; P=0.006). Positive CAD was significantly associated with HDL level (OR=0.92, 
95%CI=0.86-0.96; P=0.01) and erythrocyte sedimentation rate (OR=1.07, 
95%CI=1.02-1.13; P=0.006). Also, CAD positive patients had higher C-reactive 
protein levels than controls and it was statistically different between SVD group 














Materials and Methods 
 
3.1 Study Design 
Case control study design. 
 
3.2 Study population   
The study population included CAD patients (cases) aged 40-65 years attending 
cardiology units at Al-Shifa and Naser hospitals, Gaza Strip. Controls were 
apparently healthy non CAD individuals. 
  
3.3 Sampling and sample size 
Coronary artery disease patients were selected from cardiac units at Al-Shifa and 
Naser hospitals, Gaza Strip. Control healthy individuals with no history of CAD 
were selected from the general population. Cases and controls were matched for 
age and gender. (The sample size calculations were calculated based on the 
formula for case-control studies). EPI-INFO statistical package version 3.5.1 (EPI-
INFO, 2008) was used with 95% CI, 80% power and 50% proportion as 
conservative and OR > 2. (The sample size in cases of 1:1 ratio of case control 
was found to be 56:56). For a no-response expectation, the sample size was 
increased to 62 patients. The controls also consisted of 62 healthy individuals. 
 
 
3.4 Exclusion criteria 




3.5 Ethical Considerations 
An official letter of request sent from Ministry of Health to Al-Shifa and Naser 
hospitals, administration to facilitate the conduction of the study (Annex 1).In 
addition, The necessary approval to conduct the study was obtained from Helsinki 
committee in the Gaza Strip (Annex 2). Helsinki committee is an authorized 
professional body for giving permission to researchers to conduct their studies with 
ethical concern in the area.  
 
3.6 Data collection 
3.6.1 Questionnaire interview 
A meeting interview was used for filling in a questionnaire which designed for 
matching the study need for both cases and controls (Annex 3). All interviews 
were conducted face to face by the researcher himself. During the survey the 
interviewer explained any of the questions that were not clear. The questionnaire 
was based on the questions of a previous study with some modifications (Asfeldt 
2009, and Abu Sedo, 2012). Most questions were the yes/no questions which offer 
a dichotomous choice (Backestrom and Hursh-Cesar, 2012). The validity of the 
questionnaire was tested by six specialists in the fields of Cardiology, Microbiology 
and Public Health. The questionnaire was piloted with 8 patients not included in the 
study. The questionnaire included questions on the personal profile of the study 
population (Age, gender and education); socioeconomic data (employment, family 
income/month, family history of CAD and smoking); physical activity, diet and 
compliance of medication; diabetes, hypertension, gastritis and peptic ulcer among 
the study population.  
 
3.6.2 Body mass index 
Body mass index was calculated as the ratio of body weight in Kg/height in square 
meter. Patients were asked to remove heavy clothes and shoes before 
measurement of weight and height. Medical balance (Seca Model 762, Germany) 
was used for weight measurement. People with BMI=18.5-24.9 were considered to 
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have normal weight, people with BMI=25.0-29.9 were classified overweight, and 
people with BMI≥30.0 were considered obese (WHO, 2012).   
 
3.6.3 Specimen collection and biochemical analysis 
Twelve hours fasting overnight venous blood samples were collected from 62 CAD 
patients and 62 healthy controls. Blood samples (6 ml each) were drawn by a well 
trained nurse into vacutainer and plastic tubes from each control and CAD 
patients. About 2 ml blood was placed into EDTA vacutainer tube to perform CBC 
for cases and controls. The remainder quantity of blood (4 ml) was placed in plastic 
tube and was left for a while without anticoagulant to allow blood to clot. Serum 
samples were obtained by centrifugation at 3000 rpm for 10 minutes for 
determination of AST, LDH, CK, CKMB, cholesterol, triglycerides, HDL-C and LDL-
C. H. pylori IgG was determent in serum by enzyme immunoassay (ELISA) kit. 
(monobind ELISA kit was perches).  
 
3.7 Biochemical analysis  
 
3.7.1 Detection of H. pylori IgG 
Serum H. pylori IgG was determent by competitive ELISA for the quantitative 
determination of H. pylori IgG in human serum Catalog number 1425-300 IgG Size: 
96 wells, monobind, United states of america (USA). 
Principle 
A Sequential ELISA Method (type 1): 
The reagents required for the sequential ELISA assay include immobilized antigen, 
circulating autoantibody and enzyme-linked species-specific antibody. In this 
procedure, the immobilization takes place during the assay at the surface of a 
microplate well through the interaction of streptavidin coated on the well and 
exogenous added biotinylated H. pylori antigen. 
Upon mixing biotinylated antigen, and a serum containing the antibody, reaction 
results between the antigen and the antibody to form an immune-complex. The 
interaction is illustrated by the following equation: 
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                                                    Ka 
h-Ab(X-H. pylori) + 
BtnAg(H. pylori)                       h-Ab(X-H. pylori) - 
BtnAg(H. pylori) 
                                                    -a 
BtnAg(H. pylori) = Biotinylated Antigen (Constant Quantity) 
h-Ab(X-H. pylori)= Human Auto-Antibody (Variable Quantity) 
Ab(X-H. pylori)-
BtnAg(H. pylori) = Immune Complex (Variable Quantity) 
ka = Rate Constant of Association 
k-a = Rate Constant of Disassociation 
Simultaneously, the complex is deposited to the well through the high affinity 
reaction of streptavidin and biotinylated antigen. This interaction is illustrated 
below: 
h-Ab(X-H. pylori)-
BtnAg(H. pylori)+StreptavidinCW            immobilized complex (IC) 
StreptavidinCW = Streptavidin immobilized on well 
Immobilized complex = sandwich complex bound to the solid surface 
After the incubation time, the well is washed to separate the unbound components 
by aspiration and/or decantation. The enzyme linked species-specific antibody 
(anti-h-IgG, M or A) is then added to the microwells. This conjugates binds to the 
immune complex that formed. 
IC (h- IgG,M or A) + 
ENZAb(X-h-IgG, M or A) ⇒ 
ENZAb(X-h-IgG, M or A) - IC (h- IgG, M or A) 
IC (h- IgG, M or A) = Immobilized Immune complex (Variable Quantity) 
ENZAb(X-h-IgG, M or A) = Enzyme-antibody Conjugate (Constant Quantity) 
ENZAb(X-h-IgG, M or A) - I.C. (h- IgG, M or A) = Ag-Ab Complex (Variable) 
The anti-h-IgG, IgM or IgA enzyme conjugate that binds to the immune complex in 
a second incubation is separated from unreacted material by a wash step. The 
enzyme activity in this fraction is directly proportional to the antibody concentration 
in the specimen. By utilizing several different serum references of known antibody 
activity, a reference curve can be generated from which the antibody activity of an 
unknown can be ascertained. 
Reagents 
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A. Anti-Helicobacter pylori Calibrators – 1ml/vial 
Five vials of references for anti-H. pylori at levels of 0(A), 10(B), 25(C), 50(D), and 
100(E) U/ml of the IgG, IgM or IgA type. Store at 2-8°C. A preservative has been 
added. 
B. Helicobacter pylori Biotin Reagent – 13ml/vial 
One vial of biotinylated inactivated H. pylori (IgG, IgM or IgA) in a buffering matrix. 
A preservative has been added. Store at 2-8°C. 
C. Helicobacter pylori Enzyme Reagent – 13ml/vial 
One vial of anti-human IgG, IgM or IgA-horseradish peroxides (HRP) conjugate in 
a buffering matrix. A preservative has been added. Store at 2-8°C. 
D. Streptavidin Coated Plate – 96 wells 
One 96-well microplate coated with streptavidin and packaged in an aluminum bag 
with a drying agent. Store at 2-8°C. 
E. Serum Diluent – 20ml 
One vial of serum diluent containing buffer salts and a dye. Store at 2-8°C. 
F. Wash Solution Concentrate – 20ml 
One vial containing a surfactant in buffered saline. A preservative has been added. 
Store at 2-8°C. 
G. Substrate A – 7ml/vial 
One bottle containing tetramethylbenzidine (TMB) in buffer. Store at 2-8°C. 
H. Substrate B – 7ml/vial 
One bottle containing hydrogen peroxide (H2O2) in buffer. Store at 2-8°C. 
I. Stop Solution – 8ml/vial 
One bottle containing a strong acid (1N HCl). Store at 2-8°C. 
Specimen collection and preparation 
The specimen was blood; serum or plasma in type and the usual precautions in the 
collection of venipuncture samples were observed. For accurate comparison to 
established normal values, a fasting morning serum sample was obtained. The 
 31 
blood was collected in a plain redtop venipuncture tube without additives or anti-
coagulants (for serum) or evacuated tube(s) containing EDTA or heparin. Allow the 
blood to clot for serum samples. Centrifuge the specimen to separate the serum or 
plasma from the cells.  
Samples may be refrigerated at 2-8 C for a maximum period of 5 days. If the 
specimen(s) cannot be assayed within this time, the sample(s) may be stored at 
temperatures of -20 C for up to 30 days. Avoid use of contaminated devices. Avoid 
repetitive freezing and thawing. 
Test procedure 
Before proceeding with the assay, all reagents, serum references and controls 
were brought to room temperature (20-27°C). 
1. The microplates wells were formatted for each serum reference, control and 
patient specimen to be assayed in duplicate. 
2.  We pipetted 25μl of the appropriate serum reference, control or diluted patient 
specimen into the assigned well for IgG determination.  
3. We add 100μl of H. pylori Biotin Reagent Solution. 
4. We swirled the microplate gently for 20-30 seconds to mix and cover. 
5. We incubated 60 minutes at room temperature. 
6. We discarded the contents of the microplate by decantation or aspiration. If 
decanting, blot the plate dry with absorbent paper. 
7. We add 350μl of wash buffer, decant (blot) or aspirate. Repeat two (2) additional 
times for a total of three (3) washes.  
8. We added 100μl of H. pylori Enzyme Reagent to all wells. 
9. We cover and incubate for thirty (30) minutes at room temperature. 
10. We repeated steps (6 & 7) as explained above. Add 100μl of Working 
Substrate Solution to all wells.  
11. We incubated at room temperature for 15 minutes. 
12. We add 50μl of stop solution to each well and swirl the microplate gently for 
15-20 seconds to mix. 
13. We readied the absorbance in each well at 450nm (using a reference 




Calculation of results 
A reference curve is used to ascertain the concentration of anti-H. pylori in 
unknown specimens. 
1. We recorded the absorbance obtained from the printout of the microplate. 
2. We ploted the absorbance for each duplicate serum reference versus the 
corresponding anti-H. pylori activity in U/ml on linear graph paper (do not average 
the duplicates of the serum references before plotting). 
3. We drawed the best-fit curve through the plotted points. 
4. We determined the level of anti-H. pylori activity for an unknown, locate the 
average absorbance of the duplicates for each unknown on the vertical axis of the 
graph, find the intersecting point on the curve, and read the concentration 
in U/ml) from the horizontal axis of the graph (the duplicates of the unknown may 
be averaged as indicated). In the following example the average absorbance 1.603 
intersects the dose response curve at 64.0 U/ml anti-H. pylori concentration. 
 
3.7.2 Determination of serum aspartate aminotransferase activity 
Serum AST activity was measured by using optimized UV test according to 
international federation of clinical chemistry and laboratory medicine (Thomas 
1998), using Diasys reagent Kits. 
Principle 
The principle of the method is based on the following enzymatic reactions: 
L-Aspartate + 2-Oxoglutarate    AST   L-Glutammate + Oxalacetate 
Oxalacetate + NADH + H+    MDH      L-Malate + NAD+ 
Decrease in absorbance value at 340 nm, due to the oxidation of NADH to NAD+, 
























≥ 800 U/l 






Preparation of reagents 
 
Bireagent procedure. The reagents are liquids ready to use. 
 
Monoreagent procedure. Ten parts of Reagent A and one part of Reagent B to 
obtain the working reagent (ex. 20 ml of RA + 2 ml of RB). 
 
Analytical procedure   
About 0.5 ml of serum was transferred to the Mindray BS-300 chemistry auto 
analyzer to perform the test according to these parameters: 
 
Parameter Value 
Reagent  (μI) 200 
Serum      (μI) 20 
Incubation period (s) 15 cycle (3.5minutes) 
Reaction type Kinetic 
Wavelength (nm) 340 
Reaction  Descending 
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Reference value  
Male:  10-50 U/l 
Female:  10-35 U/l 
 
 
3.7.3 Determination of serum lactate dehydrogenase activity 
Serum LDH activity was measured by using optimized UV test  through decrease 
of the absorbance value at 340 nm, due to the NADH oxidation in NAD+, is directly 
proportional to the enzyme activity (Deutsche Gesellschaft für klinische 
Chemie, DGKC, 1972) using Diasys reagent Kits. 
Principle  
Optimized method according to DGKC. LDH catalizes the following reaction: 
         LDH 
Pyruvate + NADH + H+ → L-Lactate + NAD+ 
Decrease of the absorbance value at 340 nm, due to the NADH oxidation in NAD+, 
is directly proportional to the enzyme activity. 
 
 




Tris buffer pH 7.5 
Pyruvate  
Sodium azide  
Reagent B: 
Good buffer pH 9.6 
NADH  












Preparation of the reagents 
 
Bireagent procedure the reagents are liquids ready to use. 
 
Monoreagent procedure ten parts of Reagent A and one part of Reagent B were 
mixed to obtain the working reagent (e.g.: 20 ml of RA + 2 ml of RB). 
 
Analytical procedure   
About 0.5 ml of serum was transferred to the Mindray BS-300 chemistry auto 
analyzer to perform the test according to these parameters:  
 
Parameter Value 
Reagent  (μI) 250 
Serum      (μI) 4 
Incubation period (s) 15 cycles (3.5minutes) 
Reaction type Kinetic 




Calculation of results 
 Activity (U/l) = ΔA/min x factor (f) indicated in the following table: 
 
Monoreagent procedure 
340 nm            f = 8095 
334 nm            f = 8252 
365 nm            f = 15000 
Reference values 
 





3.7.4 Determination of serum Creatine kinase activity 
Serum CK activity was measured by using optimized UV test according to 
recommendations of the Enzyme Commission (German Society for Clinical 
Chemistry, 1977), using Diasys reagent Kits. 
 
Principle  
The CK activity is measured by the increasing rate of absorbance resulting from 
the following reactions: 
               CK (AMP, NAC) 
Creatine phosphate + ADP →Creatine + ATP 
    HK 
ATP + Glucose →ADP + G6P 
                                                                          G6P-DH 





















Preparation of the reagents 
Bireagent procedure the reagents are liquids ready to use. 
Monoreagent procedure four parts of Reagent A and one part of Reagent B were 
mixed to obtain the working reagent (e.g.: 20 ml of RA + 5 ml of RB). 
 
Analytical procedure  
About 0.5 ml of serum was transferred to the Mindray BS-300 chemistry auto 
analyzer to perform the test according to these parameters:  
Reagent Concentration 
Reagent A: 
Imidazol buffer, pH 6.7  
N-acetyl cysteine (NAC) 20 mmol/l 
Magnesium acetate  
Glucose 20 mmol/l   
HK ≥ 4 KU/l 
Reagent B: 
Creatine phosphate 30 mmol/l 
AMP  
ADP  




20 mmol/l  
10 mmol/l  
 20 mmol/l  






≥ 1.5 KU/l 
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Parameter Value 
Reagent  (μI) 200 
Serum      (μI) 10 
Incubation period (s) 15 cycles (3.5minutes) 
Reaction type Kinetic 
Wavelength (nm) 340 
Reaction Ascending 
 
Calculation of results 
CK activity (U/l) = ΔA/min x 4127 (37 °C) 
 
Reference value  
CK Male ≤ 174 U/l 
CK Female ≤ 140 U/l 
Children ≤ 225 U/l 
 
3.7.5 Determination of serum creatine kinase MB activity 
Serum CKMB activity was measured by using optimized UV test according to 
recommendations of the Enzyme Commission (German Society for Clinical 
Chemistry, 1977), using Diasys reagent Kits. 
 
Principle  
The immunoinhibition from a specific antibody of both, MM subunits and the single 
M subunit of CKMB, allows the determination of the B subunit. The CKB activity, 
corresponding to half of CKMB, is measured by the increasing rate of absorbance 
resulting from the following reactions: 
                CK (AMP, NAC) 
Creatine phosphate + ADP    →Creatine + ATP 
       HK 
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ATP + Glucose →ADP + G6P 
                                                            G6P-DH 
G6P + NADP+ + H2O →Gluconate-6P + NADPH + H+ 
 
 




Imidazol buffer, pH 6.7  
N-acetyl cysteine (NAC) 20 mmol/l 
Magnesium acetate  




Creatine phosphate 30 mmol/l 
AMP  
ADP  
Di(adenosine-5’) pentaphosphate  
G6P-DH  




20 mmol/l  
10 mmol/l  
 20 mmol/l  







≥ 1.5 KU/l 
≥ 3000 U/l of 
CK-MM at 37 °C. 
 
 
Preparation of the reagents 
 
Bireagent procedure The reagents are liquids ready to use. 
 
Monoreagent procedure Four parts of Reagent A and one part of Reagent B 




Analytical procedure   
About 0.5 ml of serum was transferred to the Mindray BS-300 chemistry auto 
analyzer to perform the test according to these parameters:  
 
Parameter Value 
Reagent  (μI) 200 
Serum      (μI) 10 
Incubation period (s) 15 cycles (3.5minutes) 
Reaction type Kinetic 
Wavelength (nm) 340 
Reaction Ascending 
 
Calculation of results 
CK-B activity (U/l) = ΔA/min x 4127 (37 °C) 
CKMB activity (U/l) = CK-B activity x 2 
 
Reference values 
CKMB, adults: 2.0 U/l ÷ 19.5 U/l (at 37 °C) 
Newborns, infants, and children have higher serum CK-MB values than adults. 
A ratio between CKMB and total CK activities above 4% should be considered 
suspicious, and above 10% consistent with acute myocardial infarction. 
 
 
3.7.6 Determination of serum cholesterol  
Serum cholesterol was determined by enzymatic colorimetric method for the 
quantitative determination of total Cholesterol in serum or plasma (Meiatlini et al, 
1978), using Diasys Diagnostic Systems, Germany. 
 
Principle 
Determination of cholesterol after enzymatic hydrolysis and oxidation, the 
colorimetric indicator is quinoneimine which is generated from 4-aminoantipyrine 
and phenol by hydrogen peroxide under the catalytic action of peroxidase. 
 41 
   
Cholesterol ester + H2O   →   cholesterol + fatty acid 
 
Cholesterol + O2      →   cholesterol-3-one + H2O2 
 
H2O2 + 4- aminoantipyrine + Phenol   →   Quinoneimine + 4 H2O 
 






≥ 200 u/l 
≥ 100 u/l 
≥ 3 ku/l 
Good,s buffer (pH 6.7)   
Phenol 
4- Aminoantipyrine 
Cholesterol esterase (CHE) 
Cholesterol oxidase (CHO) 
Peroxidase (POD) 
200 mg/dl                           Standard 
Analytical procedure   
About 0.5 ml of serum was transferred to the Mindray BS-300 chemistry auto 
analyzer to perform the test according to these parameters:  
 
Parameter Value 
Reagent  (μI) 300 
Serum      (μI) 3 
Incubation period (s) 20 cycles (4 minutes) 
Reaction type End point 











 ncentration of standard∆A sample X co
∆A standard                   
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Reference value  
 
Child (desirable)      < 170 mg/dl 
Adult (desirable)     <200 mg/dl 
 
 
3.7.7 Determination of serum triglyceride 
 
Serum triglceride was determined by enzymatic colorimetric method for the 
quantitative determination of triglyceride in serum or plasma (Bucolo and David, 




Determination of triglycerides after enzymatic splitting with lipoprotein lipase, 
indicator is quinoneimine which is generated from 4-aminoantipyrine and 4-
chlorophenol by hydrogen peroxide under the catalytic action of peroxidase.  
 
Triglycerides     →  Glycerol + fatty acid 
 
Glycerol + ATP      →  Glycerol-3-phosphate + ADP 
 
Glycerol-3-phosphate    + O2  →   Dihydroxyacetone  phosphate + H2 O2 
 








Composition of reagents 
 
Reagent Concentration 




Glycerokinase   (GK)   
Peroxidase    (POD) 
Lipoprotein lipase   (LPL) 
4-Aminoantipyrine 
Glycerol-3-phosphate-oxidase (GPO) 
50  mmol/l 
4   mmol/l 
2   mmol/l 
15 mmol/l 
≥ 0.4 KU/I 
≥  2  KU/I 
≥  2  KU/I 
0.5 mmol/l 
≥ 0.5 KU/I 
Standard 200 mg/dl 
 
Procedure   
About 0.5 ml of serum was transferred to the Mindray BS-300 chemistry auto 
analyzer to perform the test according to these parameters:   
 
Parameter Value 
Reagent  (μI) 300 
Serum      (μI) 3 
Incubation period (s) 20 cycles (4 minutes) 
Reaction type End point 





Triglycerides [mg / dl]  
 
 
 ∆A sample X concentration of standard




30 - 150 mg/dl Child (desirable) 
40 - 160 mg/dl 
35  - 135 mg/dl 
Adult (desirable)    Male  
                               Female    
 
3.7.8 Determination of serum high density lipoprotein cholesterol  
Liquid HDL-C precipitant for the determination of HDL-C was applied (Grove, 
1979), using Diasys Diagnostic Systems, Germany. 
 
Principle 
Chylomicrons, VLDL-C and LDL-C are precipitated by adding phosphotungstic acid 
and magnesium ions to the sample. Centrifugation leaves only the HDL-C in the 
supernatant, their cholesterol content is determined enzymatically using 
cholesterol reagent. 
 





8.6 mmol/l    
Monoreagent contain: Magnesium 
chloride 
 Phosphotungstic acid                 
200 mg/dl     Choesterol standard 
 
Analytical procedure  
 
1- Precipitation  
Two hundred micro liter of standard (sample or control) was added to 500 µl of the 
precipitation reagent and mixed well. 
The mixture was allowed to stand for 15 min at room temperature, and then 
centrifuged for 20 min at 4000 rpm.  
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2- Cholesterol determination 
Wavelength: 500 nm 
Optical path: 1cm 
Temperature: 37 ºC 
Measurement: against reagent blank. 
Ten micro liter of the supernatant of standard (sample or control) was added to 1 
ml of the cholesterol reagent and mixed well. 
The mixture was incubated for 5 min at 37 ºC.  
The absorbance was measured within 45 min.  
 
Calculation 
HDL-C (mg/dl) =  
 







3.7.9 Determination of serum low density lipoprotein cholesterol  
Serum LDL-C can be calculated using the empirical relationship of Friedewald 
(Friedewald et al., 1972). 
 
Principle 
The ultracentrifugal measurement of LDL-C is time consuming and expensive and 
requires special equipment. For this reason, LDL-C is most commonly estimated 
from quantitative measurements of total and HDL-C and plasma triglycerides (TG) 
using the empirical relationship of Friedewald 
The Equation 
LDL-C = Total Cholesterol – (HDL-C) - TG/5 
37 – 75 mg/dl Child 
35 – 65 mg/dl 
35 – 80 mg/dl 
Adult: Male 
           Female                  
             
 ∆A sample X concentration of standard
∆A standard                   
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3.8 Hematological parameters 
A complete system of reagents of control and calibrator, Cell-Dyne 1700 was used 
to determine the following hematological parameters: white blood cell (WBC) 
count, red blood cell (RBC) count, hemoglobin (Hb), and platelet (PLT) count. 
 
3.9 Statistical analysis 
Data were computer analyzed using SPSS/ PC (Statistical Package for the Social 
Science Inc. Chicago, Illinois USA, version 18.0) statistical package. 
 Simple distribution of the study variables and the cross tabulation 
were applied.  
 Chi-square (2) was used to identify the significance of the relations, 
associations, and interactions among various variables. Yates’s 
continuity correction test, 2(corrected), was used when not more than 
20% of the cells had an expected frequency of less than five and 
when the expected numbers were small.  
 The independent sample t-test procedure was used to compare 
means of quantitative variables by the separated cases into two 
qualitative groups such as the relationship between cases and 
controls AST enzyme. 
 The results in all the above mentioned procedures were accepted as 
statistical significant when the P-value was less than 5% (P<0.05). 
 Range as minimum and maximum values was used.  
 The percentage difference was calculated according to the formula: 
Percentage difference equals the absolute value of the change in 
value, divided by the average of the 2 numbers, all multiplied by 100. 










4.1 Personal profile of the study population 
The present study is a case control design. The study population comprised 62 
apparently healthy controls (31 males and 31 females) and 62 CAD patients which 
represent cases (31 males and 31 females). Table 4.1 illustrates personal profile of 
the study population. Age classification showed that 15 (24.2%) controls and 14 
(22.6%) cases were ≤45 years old. Age group 46-55 years comprised 25 (40.3%) 
controls and 23 (37.1%) cases. Controls and cases aged >55 years old were 22 
(35.5%) and 25 (40.3%), respectively. The difference between controls and cases 
in term of age distribution was not significant (2=0.309, P=0.857). The mean ages 
of controls and cases were 52.8±7.3 and 53.1±7.0 years old with ranges of 41-64 
and 40-65 years, respectively. The independent sample t-test also showed no 
significant difference between mean ages of controls and cases (t=0.402, 
P=0.724). Analysis of the educational status of the study population showed that 
24 (38.7%) controls and 11 (17.8%) cases had a university degree, 12 (19.4%) and 
8 (12.6%) finished secondary school, 13 (20.9%) and 17 (27.4%) passed 
preparatory school, 7 (11.3%) and 8 (12.9%) finished primary school, and 6 (9.7%) 
and 18 (29.0%) were illiterate. The difference between various educational levels 












Table 4.1 Personal profile of the study population 


































Mean±SD 52.8±7.3 53.1±7.0 t 0.402 0.724 



































































4.2 Socioeconomic data of the study population 
Table 4.2 provides socioeconomic data of the study population. The employed 
controls and cases were 37 (59.6%) and 17 (27.4%) whereas 25 (40.3%) controls 
and 45 (72.6%) cases were unemployed. The difference between the two groups 
was significant (2=13.122, P=0.000). Regarding family income\month, the number 
of cases with low income was higher than that of controls (2=12.557, P=0.002). In 
addition, family history revealed that 22 (35.5%) controls and 41 (66.1%) cases 
reported that they have family history of CAD whereas 40 (46.5%) controls and 21 
(33.9%) cases did not have family history of CAD. The difference between the two 
groups was significant (2=11.648, P=0.001) indicating that family history is 









Table 4.2 Socioeconomic data of the study population 





2 p- value 



















































































Table 4. 1 
* 
NIS: new Israeli Shekel. 
P>0.05:Not significant, P<0.05:Significant. 
 
 
4.3 Physical activity, diet and compliance of medication 
among the study population 
Physical activity, diet and compliance of medication among the study population 
are illustrated in Table 4.3. The number of cases who doing exercise was 17 
(27.4%) was lower than controls 31 (50%). The difference between the two group 
was significant (2=6.662 and P=0.008). Concerning diet, the number of controls 
and cases who followed diet were 16 (25.8%) and 30 (48.4%), respectively 





























No. % No. %   






































Compliance of medication 
Yes 





















4.4 Diabetes mellitus and hypertension among the study 
population 
Table 4.4 illustrates diabetes mellitus and hypertension among the study 
population. The number of cases who had diabetes mellitus 40 (46.5%) was 
significantly higher than that of controls 24 (38.7%), with 2=8.267 and P=0.003. In 
addition, 42 (67.7%) cases were reported hypertension compared to 8 (12.9%) 
controls (2=38.742, P=0.000).  
 








No. % No. %   















































4.5 Gastritis and peptic ulcer among the study population 
The prevalence of gastritis and peptic ulcer among the study population is 
demonstrated in Table 4.5. Gastritis was reported in 17 (27.4%) cases compared 
to14 (22.6%) controls. The difference between the two group was not significant 
(2=0.387, P=0.339). However, the reported peptic ulcer was significantly higher in 
cases compared to controls 10 (16.1%) vs. 3 (4.8%), 2 (corrected) =4.211 and 
P=0.038. 
  

















































 (corrected) test. 
P>0.05:Not Significant, P<0.05: Significant. 
 
4.6 Body mass index of the study population 
Table 4.6 provides the BMI of the study population. The mean weight of controls 
was 82.5±9.4 Kg compared to 88.5±13.1 Kg of cases. The weight difference was 
significant (t=0.287 and P=0.004) with % difference=7.0%. There was a significant 
increase in the mean height of controls compared to cases (1.73±0.08 vs 
1.68±0.07 m, % difference=2.9%, t=0.172 and P=0.000). Therefore, BMI was 
significantly increased in cases compared to controls (31.7±4.8 vs 27.6±4.4, % 























(62  100) 
88.5±13.1 
(58-122) 














13.8 0.864 0.000 
*Kg: kilogram,** m: meter. ***BMI: Body mass index: Normal=18.5-24.9, Obeys ≥30 (WHO, 
2012).All values are expressed as mean ±SD. P<0.05: Significant. 
 
4.7 Cardiac enzyme activities of the study population  
The mean activates of cardiac enzymes of the study population are presented in 
Table 4.7. There were significant elevations in the activities of AST and LDH in 
cases compared to controls (36.3±24.5 and 540.8±310.7 U/L vs 18.6±6.0 and 
321.3±66.1 U/L, % difference=64.5 and 50.9, respectively [P=0.000]). Similarly CK 
and CKMB activities were significantly higher in cases compared to controls 
(225.7±216.1 and 22.7±15.5 U/L vs 101.2±50.0 and 11.4±4.9 U/L, % 


























































67.8 5.496 0.000 
 
AST:  Aspartate transaminase, LDH: Lactate dehydrogenate, CK:  Creatine kinase, CKMB: Creatine 
kinase muscle brain all values are expressed as mean±SD. P<0.05: Significant. 
 
 
4.8 Serum lipid profile of the study population 
Table 4.8 illustrates serum lipid profile including cholesterol, triglycerides, HDL-C 
and LDL-C of the study population. The mean levels of cholesterol, triglycerides 
and LDL-C were significantly higher in cases (208.9±47.6, 218.0±110.1 and 
131.6±41.9 mg/dl, respectively) compared to controls (174.8±34.1, 167.4±57.7 and 
104.4±31.2 mg/dl, respectively) with % differences of 17.8%, 26.3%, and 23.1 and 
P=0.000, P=0.001 and P=0.000, respectively. On the other hand, the mean level of 
HDL-C was significantly lower in cases compared to controls (33.7±9.8 vs 37.6±8.4 






























  (63-323) 
218.0±110.1 
  (31-600) 














23.1 4.095 0.000 
LDL-C: Low density lipoprotein cholesterol, HDL-C: High density lipoprotein cholesterol. All values 
are expressed as mean ±SD. P<0.05: Significant. 
 
 
4.9 Blood parameters of the study population  
Table 4.9 illustrates blood parameters including white blood cell, red blood cell, 
hemoglobin and blood platelet of the study population. The white blood cell count 
was significantly higher in cases compared to controls (9.8±3.3 vs 7.8±1.6 ×109/L, 
%difference 22.7, P=0.000). However, RBC count, hemoglobin content and 












































2.2 0.881 0.380 
Hb (g/dl) 





2.3 1.061 0.291 
PLT×109/L 








WBC: White blood cell, RBC: Red blood cell, Hb: Hemoglobin, PLT: Platelet. All values are 




4.10 Distribution of Helicobacter pylori among the study 
population. 
Distribution of H. pylori among the study population is presented in Table 4.10. 
46 (74.2%) cases compared to 26 (41.9%) controls were positive for H. pylori. 
The difference between the two groups was significant (2=13.248, P=0.000) with 
higher distribution of H. pylori among cases.  
 
Table 4.10 Distribution of Helicobacter pylori among the study population 







No. (%) No. (%)   
























4.11 Relations of Helicobacter pylori 
 
4.11.1 Helicobacter pylori infection in relation to gender among 
cases. 
Table 4.11 shows the relationship between H. pylori and gender among cases. 
Although the number of males infected with H. pylori 25 (80.6%) was higher than 
that of females 21 (67.7%), the difference between the two groups was not 
significant (2=1.384 and P=0.192). 
 
Table 4.11 Helicobacter pylori infection in relation to gender among cases 






















Table 4. 4 






4.11.2 Helicobacter pylori infection in relation to cardiac enzymes 
of cases 
 
Table 4.12 gives the relationship between  H. pylori and the  cardiac enzymes. 
Although the activities of AST, LDH, CK and CKMB  enzymes were higher in H. 
pylori positive than negative cases, the differences between the two groups were 
















































AST:  Aspartate transaminase, LDH: Lactate dehydrogenate, CK:  Creatine kinase, CKMB: Creatine 
kinase muscle brain. P>0.05: Not significant. 
 
4.11.3 Helicobacter pylori infection in relation to lipid profile of 
cases 
Helicobacter pylori in relation to cholesterol, triglycerides, HDL-C and LDL-C, are 
indicated in Table 4.13. The mean level of triglyceride in positive cases was 
significantly higher than that in negative cases (235.8±112.8 vs 166.6±85.7 mg/dl, 
P=0.029).  The mean levels of cholesterol and LDL-C were also higher in positive 
than in negative cases (215.5±42.0 and 136.7±43.1 mg/dl, vs 189.7±35.8 and 
116.9±35.7 mg/dl), but the differences between the two groups were not significant 
(P=0.061 and P=0.104, respectivily). On the other hand the mean level of HDL-C 
was significantly lower in positive compared to negative cases (31.7±8.0 vs 
39.5±12.3 mg/dl, P=0.005).      
 







































HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein cholesterol. n: 
number of positive and negative cases, P>0.05: Not significant, P<0.05: Significant. 
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4.11.4 Helicobacter pylori infection in relation to blood parameters 
of cases. 
 
The relationship between H. pylori and blood parameters including WBC, RBC, Hb 
and PLT is presented in Table 4.14. The WBC count was significantly higher in 
positive compared to negative cases (10.5±3.5 vs 7.9±2.1 ×109/L P=0.007). 
However, there were no significant differences in RBC, Hb and PLT of positive 
compared to negative cases (P>0.05).   
 




































WBC: White blood cell, RBC: Red blood cell, Hb: Hemoglobin, PLT: Platelet. n: number 




4.11.5 Helicobacter pylori infection in relation to body mass index 
of cases 
 
Table 4.15 shows  the relationship between  H. pylori and the  body mass index of 
cases. There was no significant difference in body mass index between positive 
and negative cases (t=1.046, P=0.300).   
 
 


















BMI: Body mass index: Normal=18.5-24.9, Obeys ≥30 (WHO, 2012). P>0.05: Not Significant. N= 




Cardiovascular disease remains the leading cause of death in the world as well as 
in the Palestinian territories. Approximately 80% of all cardiovascular-related 
deaths occur in low- and middle-income countries and at a younger age in 
comparison to high-income countries (Gersh et al., 2010). Despite that, the 
published data on the disease were limited in the Gaza strip and most of 
information emerged from annual reports produced by the Palestinian Ministry of 
Health. Recently two studies investigated the traditional risk factors associated with 
CAD in Gaza strip (Khwaiter, 2009 and Mushtaha, 2010). However, no previous 
study investigated H. pylori in CAD patients. Therefore, this is the first study to 
assess H. pylori infection as a risk factor for CAD in Gaza strip. Understanding the 
role of H. pylori in CAD could be useful in terms of prognosis and later 
management of the disease. 
 
5.1 Socioeconomic data of the study population 
The present study is a case control investigation included 62 CAD patients (31 
males and 31 females) with mean age 53.1±7.3 years and 62 controls (31 males 
and 31 females) with mean age 52.8±7.0 years. The frequency of CAD was 
significantly higher among low educated individuals. This finding is in agreement 
with the study of Vivek (2006) who concluded that improving the level of education 
are likely to have a profound effect on the burden of premature CAD. In addition, 
CAD risk factors were reported to be associated with lower level of education in 
developing and developed countries (Franks et al, 2011 and Abu Sedo, 2012). 
 
Data on employment showed a significant increase in CAD among unemployed 
individuals compared to employed ones. Similar result was obtained by Naimi et 
al. (2009). Concerning family income\month, CAD was more frequent among less 
income family. Such finding is in accordance with that found by Franks et al. 
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(2011) who stated that people with lower socioeconomic status are much more 
likely to developed heart disease than those who are wealthier. In addition, Gersh 
et al. (2010) reported that CAD remains the leading cause of death in the world 
and approximately 80% of all cardiovascular-related deaths occur in low- and 
middle-income countries in comparison to high-income countries. 
 
Family history was found to be a risk factor of CAD. Literature review pointed out 
an association between family history and CAD (Nasir et al., 2007; 
Sivapalaratnam et al., 2010 and Qureshi, 2012). Regarding smoking, CVD was 
significantly more prevalent among smokers than non-smokers. It is known that 
smoking is a risk factor of CVD (Hossain et al., 2007; de Bobadilla et al., 2010 
and Arbab-Zadeh et al., 2012). Tobacco smoke is both prothrombotic and 
atherogenic, increasing the risks of AMI, sudden cardiac death, stroke, aortic 
aneurysm and peripheral vascular disease. Even very low doses of exposure 
increase the risk of AMI (Bullen, 2008). 
 
5.2 Physical activity and diet among the study population 
Although the number of cases who doing exercise was significantly lower than 
controls, higher number of cases were found to follow diet. Physical inactivity was 
reported as a risk factor to be associated with the development of CAD. (Kassam, 
and Stewart, 2001; Bassuk and Manson 2005; Weinstein et al.; 2008 and 
Lightfoot et al., 2010). In addition Stewart (2013) concluded that low physical 
activity was only partly explained by cardiovascular symptoms. The benefits of 
exercise can be explained on the basis of promoting weight reduction, helping 
reduce blood pressure, LDL-C and total cholesterol, and raising HDL-C levels 
(Myers, 2003). The finding that higher number of cases followed diet implies that 
the CAD patients are aware of the role of diet in the management of the disease. In 
this context, American Heart Association (2013) reported that dietary habits 
affect multiple CVD risk factors, including both established risk factors (blood 
pressure, LDL-C levels, HDL-C levels, glucose levels, and obesity/weight gain) and 
novel risk factors (e.g. inflammation, cardiac arrhythmias and endothelial cell 
function). 
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5.3 Diabetes mellitus, hypertension and peptic ulcer 
among the study population 
Diabetes mellitus and hypertension were more frequent among cases compared to 
controls. Such findings are in concurrent with results of other authors who reported 
that diabetes mellitus and hypertension are major contributors to CVD, and even 
directly or indirectly interfere and predict more serious complications of CAD 
(Esteghamati et al., 2006; Oba et al., 2008; Dorjgochoo et al., 2009; Kathryn et 
al., 2010; Borg et al., 2011; Chiha et al., 2012 and Gulin, 2013). In addition, Vats 
(2013) was found that the risk for CAD is high among diabetic patients by the 
factor of 2 to 4 as compared to non-diabetics. Higher prevalence of diabetes 
mellitus and hypertension among CAD patients may be attributed to association of 
type 2 diabetes with endothelial dysfunction as it increases the inflammation and 
insulin resistance resulting in the increase of oxidized low density lipoprotein, 
endothelin 1, angiotensin II, oxidative stress and decreasing the action of nitric 
oxide and insulin or growth factors in endothelial cells (Vats, 2013). In addition, 
Dunlay (2010) reported that hypertension and diabetes may lead to heart failure 
over longer durations via myocardial metabolic dysfunction, oxidative stress, and 
endothelial dysfunction, leading to left ventricular remodeling and cardiac 
dysfunction. The prevalence of peptic ulcer was significantly higher in cases than 
controls. In this context, Tseng (2009) concluded that peptic ulcer can occur with 
high prevalence in patients with CAD. In addition, the upper gastrointestinal 
bleeding was reported in CAD patients treated with low-dose aspirin (William et 
al., 2006).   
 
5.4 Body mass index of the study population                         
In the present study, BMI of cases was significantly higher than that of controls. In 
other words, obese individuals are at higher risk for CAD (Tripta and Sharma 
2013). The literature supported the present results in that obesity is a major risk 
factor of CAD (Achari, 2006; Rocha and Libby 2009; Jonge et al., 2011 and 
Zahidullah et al., 2012). BMI as a measure of overall adiposity is strongly 
associated with increased prevalence of CAD independent of metabolic syndrome 
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(Yao et al. 2007). Chronic obesity leads to elevated macrophages, T cells, and 
numerous inflammatory mediators and pathways in the progression of 
atherosclerosis and obesity related metabolic disorders (Rocha and Libby, 2009). 
 
5.5 Serum lipid profile of the study population 
The mean levels of cholesterol, triglycerides and LDL-C were found to be 
significantly increased in cases compared to controls. In contrast, HDL-C levels 
were significantly decreased in cases. Elevated levels of cholesterol, triglycerides 
and LDL-C, and low level of HDL-C were documented to be major risk factors for 
CAD (Onat et al., 2006; Pollar, 2010; Miller et al., 2011 and Tomkin et al., 
2012). The previous findings that cases have higher BMI compared to controls and 
obesity contributed to CAD coincides with such alterations in lipid profile. High 
levels of cholesterol, triglycerides and LDL-C, and low level of HDL-C were 
recorded in obesity (Bhatti et al., 2001; Thorpe et al., 2004 and Fox, 2011). 
 
5.6 Cardiac enzymes activities of the study population 
Laboratory assay of cardiac enzymes showed significant elevations in the activities 
of AST, LDH CK and CKMB in cases compared to controls. Similar results were 
previously reported (Kemp et al., 2004 and Davey and Atlee, 2011). The 
increments in the activities of these enzymes are expected as they believed to be 
specific biomarkers of CVD. Despite multiple known associations of elevated 
serum cardiac markers in patients with congestive heart failure, the presence of 
clinical presentation of ACS and elevated markers should alert the practitioner to 
the potential for identifiable coronary artery pathology (Glauser et al. 2007). 
 
5.7 Hematological profile of the study population 
White blood cell were significantly increased in cases compared to controls 
whereas no significant changes were found in RBC count, hemoglobin content and 
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platelet count between cases and controls. Leukocytosis was reported in CAD 
patients (Libby et al., 2010 and Moore et al., 2011). The reason of Leuckocytosis 
in CVD is still not fully understood. The proposed mechanism is based on the idea 
that elevation of WBC count may enhance atherogenesis and is also reflected in 
the inflammatory activity of atherosclerosis that causes vascular injury and tissue 
ischemia (Stocker et al., 2004 and Wu et al., 2013). In addition, WBC count 
admitted as an independent risk factor for CAD or even as independent marker of 
cardiac mortality (Sulaiman et al., 2012; Bhat et al., 2013 and Salehi et al., 
2013). 
 
5.8 Distribution of Helicobacter pylori among the study 
population 
The results of this study showed significantly higher positive H. pylori infection 46 
(74.2%) among CAD patients compared to controls 26 (41.9%). This marked 
increment in H. pylori infection in CAD patients indicates that H. pylori is 
associated with CAD. Higher prevalence of H. pylori was found among CAD 
patients (Küçükardal, 2009; AL-Obeidy and Saeedet, 2011; Vareki et al., 2013 
and Viswanath et al., 2013). The H. pylori infection in relation to other studied 
parameters amonge cases was assecd. When related to H. Pylori, triglyceride 
levels were significantly higher in positive than that in negative cases, whereas 
HDL-C levels were significantly lower in positive cases. Similar results were 
previously reported (Abu Al- Soud et al., 2008 and Viswanath et al., 2013). The 
mechanism of how H. pylori infection modifies the serum lipid profiles is still not 
clear, but a plausible explanation is that systemic inflammatory response to the 
bacterium induces changes in lipid and lipoprotein metabolism (Khovidhunkit et 
al., 2000). That is, chronic H. pylori infection has been postulated to shift the lipid 
profile toward an atherogenic direction via the action of proinflammatory cytokines, 
such as interleukins 1 and 6, interferon-alpha, and tumor necrosis factor alpha 
(TNF-α). These cytokines are capable of affecting lipid metabolism in various 
ways, including activation of adipose tissue lipoprotein lipase, stimulation of 
hepatic fatty acid synthesis, influencing lipolysis and the increasing hepatic 
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Hydroxyl methy glutary-CoA (HMG-CoA) reductase activity (Khovidhunkit et al., 
2004). Thus, H. pylori infection could play a role in the atherosclerotic process and 
may be a reliable indicator for the assessment of CVD risk (Lim et al., 2013). This 
is supported the self-reported complication of CVD reported in the present study. 
When related to H. pylori, the WBC count was significantly higher in positive 
compared to negative cases. Leukocytosis was reported in H. pylori infected 
patients (Koenig et al., 1999 and Al Soud et al., 2008). The elevation of WBC in 
H. pylori observed in infected cases may be attributed to increase production of 
inflammatory cytokines such as interleukin-8, interleukin-6, and TNF- from 




























Conclusions & Recommendations 
 
6.1 Conclusions 
1. Coronary artery disease was more prevalent among less educated and 
unemployed individuals, families with low income, individuals with family history of 
the disease as well as among smokers. 
2. The number of cases doing exercise was significantly lower than controls. 
However, the number of cases who followed diet was significantly higher than 
controls. 
3. The number of cases who had diabetes mellitus, hypertension and peptic ulcer 
was significantly higher than that of controls. 
4. The BMI was significantly higher in cases than controls. 
5. The activities of cardiac enzymes AST, LDH, CK and CKMB were significantly 
elevated in cases compared to controls. 
6. The levels of cholesterol, triglycerides and LDL-C were significantly higher in 
cases compared to controls, whereas the level of HDL-C was significantly lower in 
cases. 
7. The white blood cell count was significantly higher in cases compared to 
controls. 
9. The prevalence of H. pylori in CAD patients was significantly higher than in 
controls. 
10. When related to H. pylori, serum triglycerides levels were significantly 
increased in H. pylori positive cases than in negative cases, whereas HDL-C level 
was significantly lower in positive cases. 
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11. The WBC count was singnificantly elvated in H. pylori positive cases compared 
to negative cases. 
 
6.2 Recommendations 
1. Frequent monitoring of H. pylori infection as a risk factor of coronary artery 
disease. 
2. Estimation of lipid profile and WBC count is recommended to avoid the 
deleterious effect of H. pylori infection associated with CAD. 
3. Quitting smoking and doing exercising are recommended to decrease the risk of 
CAD, particularly in persons with family history of the disease. 
4. Further research is highly recommended on the role of H. pylori in pathogenesis 
mechanism of CAD and H. pylori infection among other chronic diseases.  
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Case control study Questionnaire for Assessment of Helicobacter pylori 
Infection as a risk factor for  Coronary Artery Disease in Gaza strip 
 
تخثی  الیثً ّ اإلسثمهٍة  الجبهعثة / هبجسثیٍس تحبلٍثط يةٍثة  بحث  (الدزاسة ُِرٍ إتوبم فً هسبعدتٌب أزجْ /الكریم المواطن أخي
 . H. pylori) ببلجسثْهثة الولٌْثة الةْابٍثة حٍ  أى ُدفٌب الْقْف علثى هسثةةبتَو ّ صب ثة عمقیثَ  ,شسٌبى القلب الیبجً بوسضى
 ّذلك للحد هي هضبعفبتَ. 
Patients and controls Questionnaire 
 
I. Sociodemographic data:  




 Address:…………………………………….Tel. No.: ………………………………………... 
 
 Education  
□ University  □ Secondary school  □ Preparatory school 
  □ Primary school  □ Illiterate 
 Employee   □Yes                 □No   
     
 Average  family income per month (shekel) 
□Less than 1000  shekel  □ 1000-2000  □ More than 2000 shekel  
 Smoke cigarettes  □Yes                 □No  
      
 Physical activity □Yes                 □No    
 
 Diet     □Yes                 □No       
 
 Family history of CAD  □Yes                 □No       
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II. Clinical data 
 
 Duration of CAD ( Years ) for patients: …………………………………………………… 
 Compliance of medication or treatments: □ Yes                   □No            
 Has diabetes:                    □Yes                 □No        
 Has hypertension:                   □Yes                  □No 
 
III. History of H. pylori infection  
 Gastritis                          □ Yes            □No  
 Peptic ulcers                         □ Yes            □No 
 Cancers of the esophagus and stomach      □ Yes            □No 
 
IV. Anthropometric measurements 
  
 Height (cm): ……………………………..Weight (kg):……………………………….  
 
 Body Mass Index: 
……………………………………………………………………………….                 
 
Agreement: I agree to complete this questionnaire concerning my health statement and for 
blood collection for laboratory analysis. 
  
لعوط الفحْ بت  ةّ اصر عٌٍة هي الدم المشه بصحیً ٌیعلق الري االسیةٍبى ُرا تعةئة على هْافق أًب
   ة.الوخةسٌ
 
 
 ...........................................  :الیْقٍع
 
 الیبزٌخ:  ..........................................
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 رمزي علي منصور/ الباحث
 
 
